Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES
In this annual report, all amounts related to United States dollars and foreign currency and to the number of Nordson Corporation’s common shares, except for per share earnings and dividend amounts, are expressed in thousands. Unless the context otherwise indicates, all references to “we,” “us,” “our,” or the “Company” mean Nordson Corporation.
Unless otherwise noted, all references to years relate to our fiscal year ending October 31.
Critical Accounting Policies and Estimates
Our Consolidated Financial Statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate the accounting policies and estimates that are used to prepare financial statements. We base our estimates on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates used by management.
Certain accounting policies that require significant management estimates and are deemed critical to our results of operations or financial position are discussed below. On a regular basis, critical accounting policies are reviewed with the Audit Committee of the board of directors.
Revenue recognition - A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Refer to Note 1 to the Consolidated Financial Statements for further discussion regarding the Company's revenue recognition policy.
Business combinations - The acquisitions of our businesses are accounted for under the acquisition method of accounting. The amounts assigned to the identifiable assets acquired and liabilities assumed in connection with acquisitions are based on estimated fair values as of the date of the acquisition, with the remainder, if any, recorded as goodwill. The fair values are determined by management, taking into consideration information supplied by the management of the acquired entities, and other relevant information. Such information typically includes valuations obtained from independent appraisal experts, which management reviews and considers in its estimates of fair values. The valuations are generally based upon future cash flow projections for the acquired assets, discounted to present value. The determination of fair values requires significant judgment by management, particularly with respect to the value of identifiable intangible assets. This judgment could result in either a higher or lower value assigned to amortizable or depreciable assets. The impact could result in either higher or lower amortization and/or depreciation expense.
Goodwill - Goodwill is the excess of purchase price over the fair value of tangible and identifiable intangible net assets acquired in various business combinations. Goodwill is not amortized but is tested for impairment annually at the reporting unit level, or more often if indications of impairment exist. Our reporting units are one level below the Industrial Precision Solutions segment, and one level below the Advanced Technology Solutions segment.
We test goodwill in accordance with Accounting Standards Codification ("ASC") 350. We did not record any goodwill impairment charges in 2021. We use an independent valuation specialist to assist with refining our assumptions and methods used to determine fair values. To test for goodwill impairment, we estimate the fair value of each of our reporting units using a combination of the Income Approach and the Market Approach.
The discounted cash flow method (Income Approach) uses assumptions for revenue growth, operating margin, and working capital turnover that are based on management’s strategic plans tempered by performance trends and reasonable expectations about those trends. Terminal value calculations employ a published formula known as the Gordon Growth Model Method that essentially captures the present value of perpetual cash flows beyond the last projected period assuming a constant Weighted Average Cost of Capital ("WACC") methodology and growth rate. For each reporting unit, a sensitivity analysis is performed to vary the discount and terminal growth rates in order to provide a range of reasonableness for detecting impairment. Discount rates are developed using a WACC methodology.
The WACC represents the blended average required rate of return for equity and debt capital based on observed market return data and company specific risk factors. For 2021, the WACC rates used ranged from 7.5 percent to 10.0 percent depending upon the reporting unit's size, end market volatility, and projection risk. See Note 6 - Goodwill and intangible assets for further details regarding the valuation methodologies used.
In 2021, 2020, and 2019, the results of our annual impairment tests indicated no impairment.
The fair value ("FV") was compared to the carrying value ("CV") for each reporting unit. Based on the results shown in the table below and based on our measurement date of August 1, 2021, our conclusion is that no goodwill was impaired in 2021. Potential events or circumstances, such as a sustained downturn in global economies, could have a negative effect on estimated fair values.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WACC
|
|
Excess of
FV over CV
|
|
Goodwill
|
Industrial Precision Solutions Segment - Adhesives
|
7.5%
|
|
865%
|
|
$
|
393,900
|
|
Industrial Precision Solutions Segment - Industrial Coating Systems
|
10.0%
|
|
982%
|
|
$
|
24,058
|
|
Advanced Technology Solutions Segment - Electronics
Systems
|
8.0%
|
|
404%
|
|
$
|
28,014
|
|
Advanced Technology Solutions Segment - Fluid
Management
|
8.0%
|
|
215%
|
|
$
|
1,177,303
|
|
Advanced Technology Solutions Segment - Test & Inspection
|
10.0%
|
|
287%
|
|
$
|
95,290
|
|
Pension plan in the United States - The measurement of the liabilities related to our domestic pension plan is based on management’s assumptions related to future factors, including interest rates, return on pension plan assets, compensation increases, mortality and turnover assumptions, and health care cost trend rates. The liabilities associated with the Company's international pension plans and OPEB are not as materially sensitive to changes in assumptions as the pension plan in the United States.
The weighted-average discount rate used to determine the present value of our domestic pension plan obligations was 3.02 percent at October 31, 2021 and 2.85 percent at October 31, 2020. The discount rate used was determined by using quality fixed income investments with a duration period approximately equal to the period over which pension obligations are expected to be settled.
In determining the expected return on plan assets, we consider both historical performance and an estimate of future long-term rates of return on assets similar to those in our plans. We consult with and consider the opinions of financial and actuarial experts in developing appropriate return assumptions. The expected rate of return (long-term investment rate) on domestic pension assets used to determine net benefit costs was 5.75 percent in both 2021 and 2020.
The assumed rate of compensation increases used to determine the present value of our domestic pension plan obligations was 4.00 percent at both October 31, 2021 and October 31, 2020.
Annual expense amounts are determined based on the discount rate used at the end of the prior year. Differences between actual and assumed investment returns on pension plan assets result in actuarial gains or losses that are amortized into expense over a period of years.
Economic assumptions have a significant effect on the amounts reported. The effect of a one percent change in the discount rate, expected return on assets and compensation increase is shown in the table below. Bracketed numbers represent decreases in expense and obligation amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
|
|
1% Point
Increase
|
|
1% Point
Decrease
|
|
|
|
|
Discount rate:
|
|
|
|
|
|
|
|
Effect on total net periodic pension cost in 2021
|
$
|
(7,223)
|
|
|
$
|
9,334
|
|
|
|
|
|
Effect on pension obligation as of October 31, 2021
|
$
|
(80,729)
|
|
|
$
|
100,948
|
|
|
|
|
|
Expected return on assets:
|
|
|
|
|
|
|
|
Effect on total net periodic pension cost in 2021
|
$
|
(4,468)
|
|
|
$
|
4,467
|
|
|
|
|
|
Compensation increase:
|
|
|
|
|
|
|
|
Effect on total net periodic pension cost in 2021
|
$
|
6,663
|
|
|
$
|
(5,794)
|
|
|
|
|
|
Effect on pension obligation as of October 31, 2021
|
$
|
32,240
|
|
|
$
|
(28,702)
|
|
|
|
|
|
Income taxes – Income taxes are estimated based on income for financial reporting purposes. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain changes in valuation allowances. We provide valuation allowances against deferred tax assets if, based on available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Management believes the valuation allowances are adequate after considering future taxable income, allowable carryforward periods and ongoing prudent and feasible tax planning strategies. In the event we were to determine that we would be able to realize the deferred tax assets in the future in excess of the net recorded amount (including the valuation allowance), an adjustment to the valuation allowance would increase income in the period such determination was made. Conversely, should we determine that we would not be able to realize all or part of the net deferred tax asset in the future, an adjustment to the valuation allowance would be expensed in the period such determination was made.
Further, at each interim reporting period, we estimate an effective income tax rate that is expected to be applicable for the full year. Significant judgment is involved regarding the application of global income tax laws and regulations and when projecting the jurisdictional mix of income. Additionally, interpretation of tax laws, court decisions or other guidance provided by taxing authorities influences our estimate of the effective income tax rates. As a result, our actual effective income tax rates and related income tax liabilities may differ materially from our estimated effective tax rates and related income tax liabilities. Any resulting differences are recorded in the period they become known.
2021 compared to 2020
Below is a detailed discussion comparison of our results of operations for the fiscal years ended October 31, 2021 and October 31, 2020. For a discussion of changes from the fiscal year ended October 31, 2020 to the fiscal year ended October 31, 2019, refer to Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended October 31, 2020.
As used throughout this annual report, geographic regions include the Americas (Canada, Mexico and Central and South America), Asia Pacific (excluding Japan), Europe, Japan, and the United States.
Worldwide sales for 2021 were $2,362,209, an increase of 11.4 percent from 2020 sales of $2,121,100. The increase consisted of a 11.3 percent improvement in sales volume and favorable currency translation effects, which increased sales by 2.7 percent partially offset by a net 2.6 percent decrease from acquisitions and divestitures.
Sales outside the United States accounted for 66.6 percent of total sales in 2021, as compared to 64.4 percent in 2020. On a geographic basis, sales in the United States were $789,303, an increase of 4.5 percent from 2020. The increase in sales consisted of a 8.3 percent increase in sales volume partially offset by a 3.8 percent decrease from acquisitions and divestitures. Sales in the Asia Pacific region were $668,035, an increase of 19.1 percent from 2020, with volume increasing 16.7 percent and favorable currency effects of 4.2 percent. partially offset by a 1.8 percent decrease from acquisitions and divestitures. Sales in Europe were $617,492, an increase of 15.1 percent from 2020. The increase in sales consisted of a 11.4 percent volume increase and favorable currency effects of 5.7 percent partially offset by a 2.0 percent decrease from acquisitions and divestitures. In the Americas region, sales were $179,807, an increase of 27.1 percent from 2020, with volume increasing 24.4 percent, favorable currency effects of 1.8 percent and a 0.9 percent increase from acquisitions and divestitures. Sales in Japan were $107,572, a decrease of 15.0 percent from 2020, with volume decreasing 11.0 percent, unfavorable currency effects of 0.5 percent and a 3.5 percent decrease from acquisitions and divestitures.
Cost of sales were $1,038,129 in 2021, up 4.8 percent from $990,632 in 2020. Gross profit, expressed as a percentage of sales, increased to 56.1 percent in 2021 from 53.3 percent in 2020. The 2.8 percentage point increase in gross margin was driven by a favorable product mix impact, principally driven by a divestiture, of 1.9 percentage points and favorable sales volume leverage.
Selling and administrative expenses were $708,953 in 2021, up from $693,552 in 2020. The 2.2 percent increase was driven by base business growth of 2.6 percentage points due primarily to increased variable incentive compensation, partially offset by reductions resulting from structural cost reduction actions taken in 2020. In addition, unfavorable currency translation effects increased costs by 2.1 percentage points. These increases were offset by a divestiture impact of 2.5 percentage points. Selling and administrative expenses as a percentage of sales decreased to 30.0 percent in 2021 from 32.7 percent in 2020. Of the 2.7 percentage point decrease, a divestiture decreased expenses by 1.2 percentage points, while sales growth leverage contributed to the remaining percentage point improvement.
Operating profit as a percentage of sales increased to 26.0 percent in 2021 compared to 16.5 percent in 2020. The 9.5 percent increase in operating margin was the result of improved operating results, specifically favorable absorption from higher sales volume and favorable product mix driven by a divestiture, and 2020 operating profit was negatively impacted by an assets held for sale impairment charge related to the 2021 product line divestiture.
Operating capacity for each of our segments can support fluctuations in order activity without significant changes in operating costs. Operating margins for each segment were favorably impacted by a weaker dollar primarily against the Euro, Chinese Yuan, and Mexican Peso during 2021 as compared to 2020.
Interest expense in 2021 was $25,491, a decrease of $6,669, or 20.7 percent, from 2020. The decrease was due to lower average debt levels compared to the prior year. Other expense in 2021 was $17,610 compared to other expense of $17,577 in 2020. Included in 2021’s other expense were pension costs of $9,484 and $5,926 in foreign currency losses. Included in the prior year’s other expense were pension costs of $13,683 and $1,532 in foreign currency losses. The decrease in pension cost was principally attributable to decreased amortization of net actuarial losses.
Income tax expense in 2021 was $119,808, or 20.9 percent of pre-tax income, as compared to $51,950, or 17.2 percent of pre-tax income in 2020. The income tax provision for 2021 included a tax benefit of $5,982 due to our share-based payment transactions. Our income tax provision for 2020 included a tax benefit of $15,661 due to our share-based payment transactions. Net income in 2020 included a non-cash, assets held for sale impairment charge of $87,371 related to our commitment to sell our screws and barrels product line within the Adhesives reporting unit under our Industrial Precision Solutions segment and the tax benefit of the impairment was $15,254. A portion of the impairment charge did not have related tax benefits.
Net income was $454,368, or $7.74 per diluted share, in 2021, compared to net income of $249,539, or $4.27 per diluted share, in 2020. This represented a 82.1 percent increase in net income and a 81.3 percent increase in diluted earnings per share. Net income in 2020 included a non-cash, assets held for sale impairment charge net of tax $72,117 related to the sale of the screws and barrels product line within the Adhesives reporting unit under our Industrial Precision Solutions segment. The remaining increase of $2.24 per diluted share was primarily driven by sales growth and mix improvement.
Industrial Precision Solutions
Sales of the Industrial Precision Solutions segment were $1,246,947 in 2021, an increase of 9.1 percent, from 2020 sales of $1,143,423. The increase was the result of an organic sales volume increase of 11.7 percent and favorable currency effects that increased sales by 3.4 percent, partially offset by a divestiture impact of 6.0 percent. Growth occurred in all product lines, except nonwovens, and in all regions except for Japan.
Operating profit as a percentage of sales increased to 33.2 percent in 2021 compared to 18.2 percent in 2020. The 15.0 percentage point improvement in operating margin was the result of improved operating results, specifically favorable absorption from higher sales volume and favorable product mix driven by a divestiture, and 2020 operating profit negatively impacted by an assets held for sale impairment charge related to a divestiture.
Advanced Technology Solutions
Sales of the Advanced Technology Solutions segment were $1,115,262 in 2021, an increase of 14.1 percent from 2020 sales of $977,677. The increase was the result of an organic sales volume increase of 10.9 percent, favorable currency effects that increased sales by 1.9 percent and a 1.3 percent increase from acquisitions. Sales growth was strong across all product lines and in all regions.
Operating profit as a percentage of sales increased to 24.4 percent in 2021 compared to 19.6 percent in 2020. The 4.8 percentage point improvement in operating margin was principally driven by greater selling and administrative expense leverage which contributed 3.1 percentage points and was associated with the sales volume growth and cost structure simplification actions taken in 2020.
Liquidity and Capital Resources
Cash and cash equivalents increased $91,679 in 2021 to $299,972 as of October 31, 2021 compared to $208,293 as of October 31, 2020. Approximately 55 percent of our consolidated cash and cash equivalents were held at various foreign subsidiaries as of October 31, 2021. On November 1, 2021, cash of $180,000 was used to fund the acquisition of NDC Technologies ("NDC") as disclosed in Note 19 to these Consolidated Financial Statements.
Cash provided by operating activities was $545,927 in 2021, compared to $502,421 in 2020. The primary sources were net income adjusted for non-cash income and expenses (consisting of depreciation and amortization, non-cash stock compensation, provision for losses on receivables, deferred income taxes, other non-cash expense, loss on sale of property, plant and equipment, and impairment loss on assets held for sale), which was $590,607 in 2021, compared to $455,490 in 2020. Changes in working capital items provided cash of $29,011 compared to $45,113 provided in 2020 as increases in receivables and inventory were partially offset by increases in other liabilities. In addition, pension cash contributions increased by $53,975 in 2021 compared to 2020 which are included in "Other - principally pension plan" in the Consolidated Statements of Cash Flows.
Cash used in investing activities was $33,169 in 2021, compared to $194,109 in 2020. In the current year, no cash was used for acquisitions compared to $142,414 used in the prior year. Capital expenditures were $38,303 in 2021 compared to $50,535 in 2020.
Cash used in financing activities was $422,913 in 2021, compared to $251,529 cash used in 2020. Net repayment of long-term debt and long-term borrowings used $289,416 of cash in 2021, compared to $153,816 used in 2020. In 2021, cash of $60,970 was used for the purchase of treasury shares, up from $52,614 used in 2020. Dividend payments were $97,683 in 2021, up from $88,347 in 2020 due to an increase in the annual dividend to $1.69 per share from $1.53 per share. Issuance of common shares related to employee benefit plans generated $31,780 of cash in 2021, down from $50,853 in 2020.
The following is a summary of significant changes by balance sheet caption from October 31, 2020 to October 31, 2021. Inventories-net increased $50,162 due to increased business activity during the year. Intangible assets-net decreased $50,219 due to amortization expense and the divestiture of our screws and barrels product line. Pension obligations decreased $84,945 primarily due to pension contributions during the second and third quarters of 2021.
Our operating performance, balance sheet position, and financial ratios for 2021 remained strong. Long-term debt decreased $286,243 during 2021 primarily due to the full repayment of our term loan due 2024. The Company is well-positioned to manage liquidity needs that arise from working capital requirements, capital expenditures, and contributions related to pension and postretirement obligations as well as principal and interest payments on our outstanding debt. Primary sources of capital to meet these needs, as well as other opportunistic investments, are a combination of cash provided by operations and borrowings under our loan agreements. Cash from operations, which when combined with our available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund our liquidity needs over the next year.
Contractual Obligations
The following table summarizes contractual obligations as of October 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
Total
|
|
Less than
1 Year
|
|
1-3
Years
|
|
4-5
Years
|
|
After 5
Years
|
Debt (1)
|
$
|
813,930
|
|
|
30,643
|
|
|
547,644
|
|
|
135,643
|
|
|
100,000
|
|
Interest payments on long-term debt (1)
|
69,161
|
|
|
18,479
|
|
|
27,762
|
|
|
13,292
|
|
|
9,628
|
|
Finance lease obligations (2)
|
23,153
|
|
|
6,162
|
|
|
6,952
|
|
|
2,512
|
|
|
7,527
|
|
Operating leases (2)
|
126,190
|
|
|
18,942
|
|
|
29,896
|
|
|
22,790
|
|
|
54,562
|
|
Contributions related to pension and postretirement
benefits (3)
|
7,175
|
|
|
7,175
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Purchase obligations (4)
|
213,972
|
|
|
212,543
|
|
|
1,349
|
|
|
40
|
|
|
40
|
|
Total obligations
|
$
|
1,253,581
|
|
|
$
|
293,944
|
|
|
$
|
613,603
|
|
|
$
|
174,277
|
|
|
$
|
171,757
|
|
(1)Refer to Note 10 to the Consolidated Financial Statements for further discussion.
(2)Refer to Note 11 to the Consolidated Financial Statements for further discussion.
(3)Pension and postretirement plan funding amounts will be determined based on the future funded status of the plans and therefore cannot be estimated at this time. Refer to Note 7 to the Consolidated Financial Statements for further discussion.
(4)Purchase obligations primarily represent commitments for materials used in our manufacturing processes that are not recorded in our Consolidated Balance Sheet.
We believe that the combination of present capital resources, cash from operations and unused financing sources such as our credit facilities are more than adequate to meet cash requirements for 2021 and beyond. There are no significant restrictions limiting the transfer of funds from international subsidiaries to the parent company.
Outlook
We are optimistic about our long-term growth opportunities in the diverse end markets we serve. We also support our customers with parts and consumables, so a significant percentage of our revenue is recurring. The combination of the Company's core strength in the direct-sales model and product innovation, combined with the Ascend Strategy, should deliver sustainable profitable growth. We expect to deliver increased sales and earnings in 2022 compared to 2021.
New Accounting Standards
Refer to Note 2 to the Consolidated Financial Statements for further discussion of recently issued accounting standards.
Effects of Foreign Currency
The impact of changes in foreign currency exchange rates on sales and operating results cannot be precisely measured due to fluctuating selling prices, sales volume, product mix and cost structures in each country where we operate. As a general rule, a weakening of the United States dollar relative to foreign currencies has a favorable effect on sales and net income, while a strengthening of the dollar has a detrimental effect.
In 2021, as compared with 2020, the United States dollar was generally weaker against foreign currencies. If 2020 exchange rates had been in effect during 2021, sales would have been approximately $55,200 lower and third -party costs would have been approximately $24,600 lower. In 2020, as compared with 2019, the United States dollar was generally stronger against foreign currencies. If 2019 exchange rates had been in effect during 2020, sales would have been approximately $5,400 higher and third-party costs would have been approximately $1,200 higher. These effects on reported sales do not include the impact of local price adjustments made in response to changes in currency exchange rates.
Trends
Our solid historical performance is attributed to our diverse geographic and end market participation and our long-term commitment to develop and provide quality products and worldwide service to meet our customers’ changing needs.
Safe Harbor Statements Under the Private Securities Litigation Reform Act of 1995
This annual report, particularly “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, income, earnings, cash flows, changes in operations, operating improvements, businesses in which we operate and the United States and global economies. Statements in this annual report that are not historical are hereby identified as “forward-looking statements” and may be indicated by words or phrases such as “anticipates,” “supports,” “plans,” “projects,” “expects,” “believes,” “should,” “would,” “could,” “hope,” “forecast,” “management is of the opinion,” use of the future tense and similar words or phrases. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions including the Company’s ability to complete and successfully integrate acquisitions, including integrating the acquisition of NDC; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, acts of terror, natural disasters and pandemics, including the current COVID-19 pandemic.
In light of these risks and uncertainties, actual events and results may vary significantly from those included in or contemplated or implied by such statements. Readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause our actual results to differ materially from the expected results are discussed in Part 1, Item 1A, Risk Factors of this annual report.
Item 8. Financial Statements and Supplementary Data
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended October 31, 2021, 2020 and 2019
|
|
|
|
|
|
|
(In thousands except for per-share amounts)
|
|
2021
|
|
2020
|
|
2019
|
Sales
|
|
$
|
2,362,209
|
|
|
$
|
2,121,100
|
|
|
$
|
2,194,226
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
Cost of sales
|
|
1,038,129
|
|
|
990,632
|
|
|
1,002,123
|
|
Selling and administrative expenses
|
|
708,953
|
|
|
693,552
|
|
|
708,990
|
|
Assets held for sale impairment charge
|
|
—
|
|
|
87,371
|
|
|
—
|
|
|
|
1,747,082
|
|
|
1,771,555
|
|
|
1,711,113
|
|
Operating profit
|
|
615,127
|
|
|
349,545
|
|
|
483,113
|
|
Other income (expense):
|
|
|
|
|
|
|
Interest expense
|
|
(25,491)
|
|
|
(32,160)
|
|
|
(47,145)
|
|
Interest and investment income
|
|
2,150
|
|
|
1,681
|
|
|
1,844
|
|
Other - net
|
|
(17,610)
|
|
|
(17,577)
|
|
|
(6,708)
|
|
|
|
(40,951)
|
|
|
(48,056)
|
|
|
(52,009)
|
|
Income before income taxes
|
|
574,176
|
|
|
301,489
|
|
|
431,104
|
|
Income tax provision:
|
|
|
|
|
|
|
Current
|
|
115,737
|
|
|
65,906
|
|
|
95,031
|
|
Deferred
|
|
4,071
|
|
|
(13,956)
|
|
|
(1,018)
|
|
|
|
119,808
|
|
|
51,950
|
|
|
94,013
|
|
Net income
|
|
$
|
454,368
|
|
|
$
|
249,539
|
|
|
$
|
337,091
|
|
Average common shares
|
|
58,091
|
|
|
57,757
|
|
|
57,462
|
|
Incremental common shares attributable to outstanding stock options, restricted stock and deferred stock-based compensation
|
|
643
|
|
|
716
|
|
|
740
|
|
Average common shares and common share equivalents
|
|
58,734
|
|
|
58,473
|
|
|
58,202
|
|
Basic earnings per share
|
|
$
|
7.82
|
|
|
$
|
4.32
|
|
|
$
|
5.87
|
|
Diluted earnings per share
|
|
$
|
7.74
|
|
|
$
|
4.27
|
|
|
$
|
5.79
|
|
Dividends declared per common share
|
|
$
|
1.69
|
|
|
$
|
1.53
|
|
|
$
|
1.43
|
|
The accompanying notes are an integral part of the consolidated financial statements.
Consolidated Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended October 31, 2021, 2020 and 2019
|
|
|
|
|
|
|
(In thousands)
|
|
2021
|
|
2020
|
|
2019
|
Net income
|
|
$
|
454,368
|
|
|
$
|
249,539
|
|
|
$
|
337,091
|
|
Components of other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
7,033
|
|
|
12,910
|
|
|
3,710
|
|
|
|
|
|
|
|
|
Pension and postretirement benefit plans:
|
|
|
|
|
|
|
Prior service (cost) credit arising during the year
|
|
124
|
|
|
(6)
|
|
|
(148)
|
|
Net actuarial gain (loss) arising during the year
|
|
25,289
|
|
|
(21,607)
|
|
|
(63,138)
|
|
Amortization of prior service cost
|
|
(304)
|
|
|
(232)
|
|
|
(322)
|
|
Amortization of actuarial loss
|
|
14,954
|
|
|
12,767
|
|
|
6,946
|
|
Settlement loss recognized
|
|
3,187
|
|
|
1,931
|
|
|
385
|
|
Total pension and postretirement benefit plans
|
|
43,250
|
|
|
(7,147)
|
|
|
(56,277)
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
50,283
|
|
|
5,763
|
|
|
(52,567)
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
$
|
504,651
|
|
|
$
|
255,302
|
|
|
$
|
284,524
|
|
The accompanying notes are an integral part of the consolidated financial statements.
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2021 and 2020
|
|
|
|
|
(In thousands)
|
|
|
|
|
Assets
|
|
|
|
|
Current assets:
|
|
2021
|
|
2020
|
Cash and cash equivalents
|
|
$
|
299,972
|
|
|
$
|
208,293
|
|
Receivables - net
|
|
489,389
|
|
|
471,873
|
|
Inventories - net
|
|
327,195
|
|
|
277,033
|
|
Prepaid expenses and other current assets
|
|
48,282
|
|
|
43,798
|
|
Assets held for sale
|
|
—
|
|
|
19,615
|
|
Total current assets
|
|
1,164,838
|
|
|
1,020,612
|
|
Property, plant and equipment - net
|
|
355,565
|
|
|
358,618
|
|
Operating right of use lease assets
|
|
110,851
|
|
|
122,125
|
|
Goodwill
|
|
1,713,148
|
|
|
1,713,354
|
|
Intangible assets - net
|
|
357,367
|
|
|
407,586
|
|
Deferred income taxes
|
|
11,381
|
|
|
9,831
|
|
Other assets
|
|
77,811
|
|
|
42,530
|
|
|
|
$
|
3,790,961
|
|
|
$
|
3,674,656
|
|
Liabilities and shareholders' equity
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
91,689
|
|
|
$
|
70,949
|
|
Income taxes payable
|
|
16,636
|
|
|
7,841
|
|
Accrued liabilities
|
|
201,992
|
|
|
167,883
|
|
Customer advance payments
|
|
77,868
|
|
|
42,323
|
|
Current maturities of long - term debt
|
|
34,188
|
|
|
38,043
|
|
Operating lease liability - current
|
|
17,222
|
|
|
16,918
|
|
Finance lease liability
|
|
5,799
|
|
|
5,984
|
|
Liabilities held for sale
|
|
—
|
|
|
13,148
|
|
Total current liabilities
|
|
445,394
|
|
|
363,089
|
|
Long-term debt
|
|
781,709
|
|
|
1,067,952
|
|
Operating lease liability - noncurrent
|
|
97,685
|
|
|
109,317
|
|
Finance lease liability - noncurrent
|
|
14,944
|
|
|
10,470
|
|
Pension obligations
|
|
80,584
|
|
|
165,529
|
|
Postretirement obligations
|
|
82,652
|
|
|
85,249
|
|
Deferred income taxes
|
|
88,467
|
|
|
66,995
|
|
Other long-term liabilities
|
|
40,396
|
|
|
47,064
|
|
Shareholders' equity:
|
|
|
|
|
Preferred shares, no par value; 10,000 shares authorized;
|
|
|
|
|
none issued
|
|
—
|
|
|
—
|
|
Common shares, no par value; 160,000 shares authorized;
|
|
|
|
|
98,023 shares issued at October 31, 2021 and 2020
|
|
12,253
|
|
|
12,253
|
|
Capital in excess of stated value
|
|
585,334
|
|
|
534,684
|
|
Retained earnings
|
|
3,265,027
|
|
|
2,908,738
|
|
Accumulated other comprehensive loss
|
|
(175,835)
|
|
|
(226,118)
|
|
Common shares in treasury, at cost
|
|
(1,527,649)
|
|
|
(1,470,566)
|
|
Total shareholders' equity
|
|
2,159,130
|
|
|
1,758,991
|
|
|
|
$
|
3,790,961
|
|
|
$
|
3,674,656
|
|
The accompanying notes are an integral part of the consolidated financial statements.
Consolidated Statements of Shareholders’ Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended October 31, 2021, 2020 and 2019
|
|
(In thousands, except for per share data)
|
Common
Shares
|
|
Additional
Paid-in-
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Common
Shares in
Treasury,
at cost
|
|
TOTAL
|
October 31, 2018
|
$
|
12,253
|
|
|
$
|
446,555
|
|
|
$
|
2,488,375
|
|
|
$
|
(179,314)
|
|
|
$
|
(1,317,128)
|
|
|
$
|
1,450,741
|
|
Shares issued under company stock and employee benefit plans
|
—
|
|
|
18,475
|
|
|
—
|
|
|
—
|
|
|
7,545
|
|
|
26,020
|
|
Stock-based compensation
|
—
|
|
|
18,086
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,086
|
|
Purchase of treasury shares (998,004 shares)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(120,510)
|
|
|
(120,510)
|
|
Dividends declared ($1.43 per share)
|
—
|
|
|
—
|
|
|
(82,145)
|
|
|
—
|
|
|
—
|
|
|
(82,145)
|
|
Net income
|
—
|
|
|
—
|
|
|
337,091
|
|
|
—
|
|
|
—
|
|
|
337,091
|
|
Reclassification due to adoption of ASU 2014-09
|
—
|
|
|
—
|
|
|
4,329
|
|
|
—
|
|
|
—
|
|
|
4,329
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
3,710
|
|
|
—
|
|
|
3,710
|
|
Defined benefit pension and post-retirement plans adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
(56,277)
|
|
|
—
|
|
|
(56,277)
|
|
October 31, 2019
|
$
|
12,253
|
|
|
$
|
483,116
|
|
|
$
|
2,747,650
|
|
|
$
|
(231,881)
|
|
|
$
|
(1,430,093)
|
|
|
$
|
1,581,045
|
|
Shares issued under company stock and employee benefit plans
|
—
|
|
|
38,712
|
|
|
—
|
|
|
—
|
|
|
12,141
|
|
|
50,853
|
|
Stock-based compensation
|
—
|
|
|
12,856
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,856
|
|
Purchase of treasury shares (384,498 shares)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,614)
|
|
|
(52,614)
|
|
Dividends declared ($1.53 per share)
|
—
|
|
|
—
|
|
|
(88,347)
|
|
|
—
|
|
|
—
|
|
|
(88,347)
|
|
Net income
|
—
|
|
|
—
|
|
|
249,539
|
|
|
—
|
|
|
—
|
|
|
249,539
|
|
Impact of adoption of ASU 2016-02
|
—
|
|
|
—
|
|
|
(104)
|
|
|
—
|
|
|
—
|
|
|
(104)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
12,910
|
|
|
—
|
|
|
12,910
|
|
Defined benefit pension and post-retirement plans adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,147)
|
|
|
—
|
|
|
(7,147)
|
|
October 31, 2020
|
$
|
12,253
|
|
|
$
|
534,684
|
|
|
$
|
2,908,738
|
|
|
$
|
(226,118)
|
|
|
$
|
(1,470,566)
|
|
|
$
|
1,758,991
|
|
Shares issued under company stock and employee benefit plans
|
—
|
|
|
27,893
|
|
|
—
|
|
|
—
|
|
|
3,887
|
|
|
31,780
|
|
Stock-based compensation
|
—
|
|
|
22,757
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,757
|
|
Purchase of treasury shares (291,253 shares)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(60,970)
|
|
|
(60,970)
|
|
Dividends declared ($1.69 per share)
|
—
|
|
|
—
|
|
|
(97,683)
|
|
|
—
|
|
|
—
|
|
|
(97,683)
|
|
Net income
|
—
|
|
|
—
|
|
|
454,368
|
|
|
—
|
|
|
—
|
|
|
454,368
|
|
Impact of adoption of ASU 2016-13
|
—
|
|
|
—
|
|
|
(396)
|
|
|
—
|
|
|
—
|
|
|
(396)
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
7,033
|
|
|
—
|
|
|
7,033
|
|
Defined benefit pension and post-retirement plans adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
43,250
|
|
|
—
|
|
|
43,250
|
|
October 31, 2021
|
$
|
12,253
|
|
|
$
|
585,334
|
|
|
$
|
3,265,027
|
|
|
$
|
(175,835)
|
|
|
$
|
(1,527,649)
|
|
|
$
|
2,159,130
|
|
The accompanying notes are an integral part of the consolidated financial statements.
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended October 31, 2021, 2020 and 2019
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
2021
|
|
2020
|
|
2019
|
Net income
|
|
$
|
454,368
|
|
|
$
|
249,539
|
|
|
$
|
337,091
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
Depreciation
|
|
53,332
|
|
|
56,323
|
|
|
55,454
|
|
Amortization
|
|
50,551
|
|
|
56,979
|
|
|
54,790
|
|
Provision for losses on receivables
|
|
32
|
|
|
2,165
|
|
|
2,254
|
|
Deferred income taxes
|
|
4,071
|
|
|
(13,956)
|
|
|
(1,018)
|
|
Non-cash stock compensation
|
|
22,757
|
|
|
12,856
|
|
|
18,086
|
|
Loss on sale of property, plant and equipment
|
|
589
|
|
|
484
|
|
|
953
|
|
Impairment loss on assets held for sale
|
|
—
|
|
|
87,371
|
|
|
—
|
|
Other non-cash
|
|
4,907
|
|
|
3,729
|
|
|
(669)
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Receivables
|
|
(13,720)
|
|
|
50,098
|
|
|
(39,992)
|
|
Inventories
|
|
(50,584)
|
|
|
5,785
|
|
|
(23,117)
|
|
Prepaid expenses
|
|
(5,209)
|
|
|
1,978
|
|
|
(2,024)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
20,769
|
|
|
(10,673)
|
|
|
654
|
|
Income taxes payable
|
|
8,659
|
|
|
(7,816)
|
|
|
(3,832)
|
|
Accrued liabilities
|
|
32,929
|
|
|
6,360
|
|
|
(14,027)
|
|
Customer advance payments
|
|
36,167
|
|
|
(619)
|
|
|
2,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other - principally pension plan
|
|
(73,691)
|
|
|
1,818
|
|
|
(3,903)
|
|
Net cash provided by operating activities
|
|
545,927
|
|
|
502,421
|
|
|
382,893
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
Additions to property, plant and equipment
|
|
(38,303)
|
|
|
(50,535)
|
|
|
(64,244)
|
|
Proceeds from sale of property, plant and equipment
|
|
163
|
|
|
840
|
|
|
1,285
|
|
Acquisition of businesses, net of cash acquired
|
|
—
|
|
|
(142,414)
|
|
|
(12,486)
|
|
Other
|
|
4,971
|
|
|
(2,000)
|
|
|
(844)
|
|
Net cash used in investing activities
|
|
(33,169)
|
|
|
(194,109)
|
|
|
(76,289)
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from long-term debt
|
|
9,414
|
|
|
165,734
|
|
|
186,635
|
|
Repayment of long-term debt
|
|
(298,830)
|
|
|
(319,550)
|
|
|
(254,473)
|
|
Repayment of capital lease obligations
|
|
(6,624)
|
|
|
(7,605)
|
|
|
(4,859)
|
|
Payment of debt issuance costs
|
|
—
|
|
|
—
|
|
|
(1,742)
|
|
Issuance of common shares
|
|
31,780
|
|
|
50,853
|
|
|
26,020
|
|
Purchase of treasury shares
|
|
(60,970)
|
|
|
(52,614)
|
|
|
(120,510)
|
|
Dividends paid
|
|
(97,683)
|
|
|
(88,347)
|
|
|
(82,145)
|
|
Net cash used in financing activities
|
|
(422,913)
|
|
|
(251,529)
|
|
|
(251,074)
|
|
Effect of exchange rate changes on cash
|
|
1,834
|
|
|
346
|
|
|
(44)
|
|
Increase in cash and cash equivalents
|
|
91,679
|
|
|
57,129
|
|
|
55,486
|
|
Cash and cash equivalents at beginning of year
|
|
208,293
|
|
|
151,164
|
|
|
95,678
|
|
Cash and cash equivalents at end of year
|
|
$
|
299,972
|
|
|
$
|
208,293
|
|
|
$
|
151,164
|
|
The accompanying notes are an integral part of the consolidated financial statements.
Notes to Consolidated Financial Statements
NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES
In this annual report, all amounts related to United States dollars and foreign currency and to the number of Nordson Corporation’s common shares, except for per share earnings and dividend amounts, are expressed in thousands. Unless the context otherwise indicates, all references to “we” or the “Company” mean Nordson Corporation.
Unless otherwise noted, all references to years relate to our fiscal year.
Note 1 — Significant accounting policies
Consolidation — The consolidated financial statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50 percent or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of estimates — The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and notes. Actual amounts could differ from these estimates.
Fiscal year — Our fiscal year is November 1 through October 31.
Revenue recognition — A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of October 31, 2021 and 2020 were not material.
However, for certain contracts related to the sale of customer-specific products within our Advanced Technology Solutions segment, revenue is recognized for these contracts over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin.
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at October 31, 2021 or 2020. Revenue recognized over time represented approximately ten percent of our overall consolidated revenues at October 31, 2021 or 2020.
Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling, general and administrative expenses in our Consolidated Statements of Income.
We offer assurance type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, therefore, are typically regarded as inconsequential or not material.
We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to Note 16 for details on our operating segments.
Notes to Consolidated Financial Statements — (Continued)
Shipping and handling costs — Amounts billed to customers for shipping and handling are recorded as revenue. Shipping and handling expenses are included in cost of sales.
Advertising costs — Advertising costs are expensed as incurred and were $5,986, $7,174 and $10,479 in 2021, 2020 and 2019, respectively.
Research and development — Investments in research and development are important to our long-term growth, enabling us to keep pace with changing customer and marketplace needs through the development of new products and new applications for existing products. We place strong emphasis on technology developments and improvements through internal engineering and research teams. Research and development costs are expensed as incurred and were $59,422, $63,591 and $60,018 in 2021, 2020 and 2019, respectively. As a percentage of sales, research and development expenses were 2.5, 3.0 and 2.7 percent in 2021, 2020 and 2019, respectively.
Earnings per share — Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted stock and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options for 46 common shares were excluded from the diluted earnings per share calculation in 2021 and 95 and 176 options were excluded from the calculation of diluted earnings per share in 2020 and 2019, respectively because their effect would have been anti-dilutive. Under the Amended and Restated 2012 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share.
Cash and cash equivalents — Highly liquid instruments with maturities of 90 days or less at date of purchase are considered to be cash equivalents.
Allowance for doubtful accounts — An allowance for doubtful accounts is maintained for estimated losses resulting from the inability of customers to make required payments. The amount of the allowance is determined principally on the basis of past collection experience and known factors regarding specific customers. Accounts are written off against the allowance when it becomes evident that collection will not occur. Credit is extended to customers satisfying pre-defined credit criteria. We believe we have limited concentration of credit risk due to the diversity of our customer base.
Our primary allowance for credit losses is the allowance for doubtful accounts, which is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.
Accounts receivable are net of an allowance for credit losses of $7,552 and $9,045 at October 31, 2021 and October 31, 2020, respectively. The change in the allowance for expected credit losses includes an immaterial accounting standard adoption impact from ASU 2016-13 of $396 for the twelve months ended October 31, 2021. The provision for losses on receivables was $32 for the twelve months ended October 31, 2021, respectively, compared to $2,165 for the same periods a year ago, respectively. The remaining change in the allowance for credit losses is principally related to the write-off of uncollectible accounts.
Inventories — Inventories are valued at the lower of cost or net realizable value. Cost was determined using the last-in, first-out (LIFO) method for 16 percent of consolidated inventories at October 31, 2021 and 19 percent of consolidated inventories at October 31, 2020. The first-in, first-out (FIFO) method is used for all other inventories. Consolidated inventories would have been $4,216 and $4,545 higher than reported at October 31, 2021 and 2020, respectively, had the FIFO method, which approximates current cost, been used for valuation of all inventories.
Property, plant and equipment and depreciation — Property, plant and equipment are carried at cost. Additions and improvements that extend the lives of assets are capitalized, while expenditures for repairs and maintenance are expensed as incurred. Plant and equipment are depreciated for financial reporting purposes using the straight-line method over the estimated useful lives of the assets or, in the case of property under finance leases, over the terms of the leases. Leasehold improvements are depreciated over the shorter of the lease term or their useful lives.
Notes to Consolidated Financial Statements — (Continued)
Useful lives are as follows:
|
|
|
|
|
|
Land improvements
|
15-25 years
|
Buildings
|
20-40 years
|
Machinery and equipment
|
3-18 years
|
Enterprise management systems
|
5-13 years
|
Depreciation expense is included in cost of sales and selling and administrative expenses. Internal use software costs are expensed or capitalized depending on whether they are incurred in the preliminary project stage, application development stage or the post-implementation stage. Amounts capitalized are amortized over the estimated useful lives of the software beginning with the project’s completion. All re-engineering costs are expensed as incurred. Interest costs on significant capital projects are capitalized. No interest was capitalized in 2021, 2020 or 2019.
Goodwill and intangible assets — Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill relates to and is assigned directly to specific reporting units. Goodwill is not amortized but is subject to annual impairment testing. Our annual impairment testing is performed as of August 1. Testing is done more frequently if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets.
Other amortizable intangible assets, which consist primarily of patent/technology costs, customer relationships, noncompete agreements, and trade names, are amortized over their useful lives on a straight-line basis. At October 31, 2021, the weighted-average useful lives for each major category of amortizable intangible assets were:
|
|
|
|
|
|
Patent/technology costs
|
12 years
|
Customer relationships
|
14 years
|
Noncompete agreements
|
4 years
|
Trade names
|
15 years
|
Foreign currency translation — The financial statements of subsidiaries outside the United States are generally measured using the local currency as the functional currency. Assets and liabilities of these subsidiaries are translated at the rates of exchange at the balance sheet dates. Income and expense items are translated at average monthly rates of exchange. The resulting translation adjustments are included in accumulated other comprehensive income (loss), a separate component of shareholders’ equity. Generally, gains and losses from foreign currency transactions, including forward contracts, of these subsidiaries and the United States parent are included in net income. Gains and losses from intercompany foreign currency transactions of a long-term investment nature are included in accumulated other comprehensive income (loss).
Accumulated other comprehensive loss — Accumulated other comprehensive loss at October 31, 2021 and 2020 consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative
translation
adjustments
|
|
Pension and
postretirement benefit
plan adjustments
|
|
Accumulated
other comprehensive
loss
|
Balance at October 31, 2020
|
$
|
(40,422)
|
|
|
$
|
(185,696)
|
|
|
$
|
(226,118)
|
|
Pension and postretirement plan changes, net of tax of $(12,938)
|
—
|
|
|
43,250
|
|
|
43,250
|
|
Currency translation losses
|
7,033
|
|
|
—
|
|
|
7,033
|
|
Balance at October 31, 2021
|
$
|
(33,389)
|
|
|
$
|
(142,446)
|
|
|
$
|
(175,835)
|
|
Warranties — We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in accrued liabilities in the Consolidated Balance Sheet.
Notes to Consolidated Financial Statements — (Continued)
Following is a reconciliation of the product warranty liability as of October 31, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
Balance at beginning of year
|
$
|
10,550
|
|
|
$
|
11,006
|
|
Accruals for warranties
|
16,011
|
|
|
11,662
|
|
Warranty payments
|
(15,475)
|
|
|
(12,330)
|
|
Currency adjustments
|
27
|
|
|
212
|
|
Balance at end of year
|
$
|
11,113
|
|
|
$
|
10,550
|
|
Note 2 — Recently issued accounting standards
New accounting guidance adopted:
In June 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326),” which changed the impairment model for most financial instruments. Prior guidance required the recognition of credit losses based on an incurred loss impairment methodology that reflected losses once the losses are probable. We adopted the new standard on November 1, 2020 and are now applying a current expected credit loss model that requires recognizing an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of the update, including trade receivables. The standard requires judgment and consideration of historical information, current information, and reasonable and supportable forecasts, as well as the impact of any prepayments. In addition, we reviewed our business processes and controls to support the recognition and disclosure as required under the new standard. The adoption of this new standard did not have a material impact on our Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other Internal – Use Software (Subtopic 350-40),” which is meant to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement), by providing guidance in determining when the arrangement includes a software license. We adopted the new standard on November 1, 2020. Hosted arrangements deemed to be in scope will follow the capitalization criteria for implementation costs as though they were internal-use computer software. There may be multiple elements besides the software license (such as: training, future upgrades, data conversion, and other elements) which require the allocation of the contract price to each of the elements; entities are to capitalize only those elements which meet the capitalization criteria. Capitalized implementation costs are amortized over the term of the hosted arrangement including consideration for renewal or termination options. In addition, we reviewed our business processes and controls to support the recognition and disclosure as required under the new standard. The adoption of this new standard did not have a material impact on our Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20),” a new standard which addresses defined benefit plans. The amendments modify the following disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans: the amounts in accumulated other comprehensive income expected to be recognized as components of net period benefit cost over the next fiscal year, amount and timing of plan assets expected to be returned to the employer, related party disclosure about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan, and the effects of a 1.00 percent point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligations for postretirement health care benefits are removed. A disclosure requirement was added for the explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Additionally, the standard clarifies disclosure requirements surrounding the projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets and the accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets. We adopted the new standard and revised disclosures as reflected in Note 7 with no material impact to the Consolidated Financial Statements.
In August 2018, the FASB issued a new standard which removes, modifies, and adds certain disclosure requirements on fair value measurements. The guidance removes disclosure requirements pertaining to the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. For investments in certain entities that calculate net asset value, an entity is required to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. In addition, the amendment clarifies that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date. The guidance adds disclosure requirements for changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period as well as
Notes to Consolidated Financial Statements — (Continued)
the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. We adopted the new standard on November 1, 2020 with no material impact to the Consolidated Financial Statements.
In December 2019, the FASB issued ASU 2019-12, “Income Taxes (ASC 740) – Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of ASC 740 by clarifying and amending existing guidance. We adopted the new standard on November 1, 2020 with no material impact to the Consolidated Financial Statements.
Note 3 — Acquisitions
Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Consolidated Statement of Income.
2020 acquisitions
On September 1, 2020, we acquired 100 percent of the outstanding shares of vivaMOS Ltd. ("vivaMOS"), a developer and fabricator of high-end large-area complementary metal–oxide–semiconductor ("CMOS") image sensors for a wide range of X-ray applications. We acquired vivaMOS for an aggregate purchase price of $17,154 net of cash and other closing adjustments of approximately $158, utilizing cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $14,394 and identifiable intangible assets of $4,040 were recorded. The identifiable intangible assets consist primarily of $3,900 of technology (amortized over 10 years) and $140 of non-compete agreements (amortized over 3 years). Goodwill associated with this acquisition was not tax deductible. This acquisition is being reported in our Advanced Technology Solutions segment and the results of vivaMOS were not material to our Consolidated Financial Statements.
On June 1, 2020, we acquired 100 percent of the outstanding shares of Fluortek, Inc. ("Fluortek"), a precision plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. We acquired Fluortek for an aggregate purchase price of $125,260, net of cash and other closing adjustments of approximately $515, utilizing cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, property, plant and equipment and working capital – net of $19,843, goodwill of $76,047 and identifiable intangible assets of $29,370 were recorded. The identifiable intangible assets consist primarily of $19,700 of customer relationships (amortized over 12 years), $7,400 of technology (amortized over 10 years), $1,500 of tradenames (amortized over 10 years), and $770 of non-compete agreements (amortized over 5 years). Goodwill associated with this acquisition was tax deductible. This acquisition is being reported in our Advanced Technology Solutions segment and the results for Fluortek were not material to the our Consolidated Financial Statements.
2019 acquisition
On July 1, 2019, we purchased certain assets of Optical Control GmbH & Co. KG ("Optical"), a Nuremberg, Germany designer and developer of high speed, fully automatic counting systems utilizing x-ray technology. This transaction was not material to our Consolidated Financial Statements. We recorded the acquisition of Optical based on the fair value of the assets acquired and the liabilities assumed. Goodwill associated with this acquisition is tax deductible. This acquisition is being reported in our Advanced Technology Solutions segment.
Note 4 — Divestiture
In the fourth quarter of 2020, we committed to a plan to sell our screws and barrels product line within our Industrial Precision Solutions operating segment and determined the criteria to be classified as held for sale were met. We entered into a letter of intent to sell the screws and barrels product line in October 2020, and in December 2020, we entered into a definitive agreement with the buyer. The assets and liabilities were presented as held for sale in the Condensed Consolidated Balance Sheets and measured at the lower of carrying value or fair value less cost to sell from October 31, 2021 until the transaction was completed on February 1, 2021.
Before measuring the fair value less costs to sell of the disposal group as a whole, we first reviewed individual assets and liabilities to determine if any fair value adjustments were required and concluded no individual asset impairments were required. Then, based on the definitive agreement entered into by us and the buyer, we determined the fair value of the disposal group to be equal to the selling price, less costs to sell. Based on this review, we recorded a non-cash, assets held for sale impairment charge of $87,371 in 2020.
Notes to Consolidated Financial Statements — (Continued)
The assets and liabilities of the screws and barrels product line classified as held for sale at October 31, 2020 were as follows:
|
|
|
|
|
|
|
|
|
2020
|
|
|
Receivables - net
|
$
|
14,327
|
|
|
|
Inventories - net
|
9,854
|
|
|
|
Prepaid expenses and other current assets
|
696
|
|
|
|
Property, plant and equipment - net
|
58,950
|
|
|
|
Other assets
|
23,159
|
|
|
|
Impairment on carrying value
|
(87,371)
|
|
|
|
Assets held for sale
|
$
|
19,615
|
|
|
|
|
|
|
|
Accounts payable
|
$
|
4,625
|
|
|
|
Accrued liabilities
|
3,352
|
|
|
|
Other liabilities
|
5,171
|
|
|
|
Liabilities held for sale
|
$
|
13,148
|
|
|
|
Excluding the non-cash, assets held for sale impairment charge recorded in the fourth quarter of 2020, the operating results of the screws and barrels product line were not material to our Consolidated Financial Statements for any period presented. There were no significant adjustments in 2021 to the loss recognized in 2020.
Notes to Consolidated Financial Statements — (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
Note 5 — Details of Consolidated Balance Sheet
|
2021
|
|
2020
|
Receivables:
|
|
|
|
Accounts
|
$
|
479,594
|
|
|
$
|
445,360
|
|
Notes
|
2,504
|
|
|
4,592
|
|
Other
|
14,843
|
|
|
30,966
|
|
|
496,941
|
|
|
480,918
|
|
Allowance for doubtful accounts
|
(7,552)
|
|
|
(9,045)
|
|
|
$
|
489,389
|
|
|
$
|
471,873
|
|
Inventories:
|
|
|
|
Raw materials and component parts
|
$
|
111,089
|
|
|
$
|
94,630
|
|
Work-in-process
|
54,557
|
|
|
44,403
|
|
Finished goods
|
211,628
|
|
|
183,860
|
|
|
377,274
|
|
|
322,893
|
|
Obsolescence and other reserves
|
(45,863)
|
|
|
(41,315)
|
|
LIFO reserve
|
(4,216)
|
|
|
(4,545)
|
|
|
$
|
327,195
|
|
|
$
|
277,033
|
|
Property, plant and equipment:
|
|
|
|
Land
|
$
|
9,238
|
|
|
$
|
8,816
|
|
Land improvements
|
4,786
|
|
|
4,611
|
|
Buildings
|
263,399
|
|
|
253,621
|
|
Machinery and equipment
|
491,180
|
|
|
464,171
|
|
Enterprise management system
|
50,532
|
|
|
56,103
|
|
Construction-in-progress
|
32,719
|
|
|
29,897
|
|
Leased property under finance leases
|
37,506
|
|
|
32,590
|
|
|
889,360
|
|
|
849,809
|
|
Accumulated depreciation and amortization
|
(533,795)
|
|
|
(491,191)
|
|
|
$
|
355,565
|
|
|
$
|
358,618
|
|
Accrued liabilities:
|
|
|
|
Salaries and other compensation
|
$
|
87,066
|
|
|
$
|
52,260
|
|
Pension and retirement
|
5,622
|
|
|
10,282
|
|
Taxes other than income taxes
|
13,095
|
|
|
13,346
|
|
Customer commissions
|
10,460
|
|
|
9,158
|
|
Other
|
85,749
|
|
|
82,837
|
|
|
$
|
201,992
|
|
|
$
|
167,883
|
|
Note 6 — Goodwill and intangible assets
We account for goodwill and other intangible assets in accordance with the provisions of ASC 350 and account for business combinations using the acquisition method of accounting and accordingly, the assets and liabilities of the entities acquired are recorded at their estimated fair values at the acquisition date. Goodwill is the excess of purchase price over the fair value of tangible and identifiable intangible net assets acquired in various business combinations. Goodwill is not amortized but is subject to annual impairment testing. Our annual impairment testing is performed as of August 1. Testing is done more frequently if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets. We assess the fair value of reporting units on a non-recurring basis using a quantitative analysis that uses a combination of the discounted cash flow method of the Income Approach and the guideline public company method of the Market Approach, and compare the result against the reporting unit’s carrying value of net assets. The implied fair value of our reporting units is determined based on significant unobservable inputs, as discussed below; accordingly, these inputs fall within Level 3 of the fair value hierarchy. The discounted cash flow method (Income Approach) uses assumptions for revenue growth, operating margin, and working capital turnover that are based on management’s strategic plans tempered by performance trends and reasonable expectations about those trends. Terminal value calculations employ a published formula
Notes to Consolidated Financial Statements — (Continued)
known as the Gordon Growth Model Method that essentially captures the present value of perpetual cash flows beyond the last projected period assuming a constant Weighted Average Cost of Capital (WACC) methodology and growth rate. For each reporting unit, a sensitivity analysis is performed to vary the discount and terminal growth rates in order to provide a range of reasonableness for detecting impairment. Discount rates are developed using a WACC methodology. The WACC represents the blended average required rate of return for equity and debt capital based on observed market return data and company specific risk factors.
In the application of the guideline public company method (Market Approach), fair value is determined using transactional evidence for similar publicly traded equity. The comparable company guideline group is determined based on relative similarities to each reporting unit since exact correlations are not available. An indication of fair value for each reporting unit is based on the placement of each reporting unit within a range of multiples determined for its comparable guideline company group. Valuation multiples are derived by dividing latest twelve-month performance for revenues and Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) into total invested capital, which is the sum of traded equity plus interest bearing debt less cash. These multiples are applied against the revenue and EBITDA of each reporting unit. While the implied indications of fair value using the guideline public company method yield meaningful results, the discounted cash flow method of the income approach includes management’s thoughtful projections and insights as to what the reporting units will accomplish in the near future. Accordingly, the reasonable, implied fair value of each reporting unit is a blend based on the consideration of both the Income and Market approaches.
An impairment charge is recorded for the amount by which the carrying value of the reporting unit exceeds the fair value of the reporting unit, as calculated in the quantitative analysis described above. Based on our annual impairment tests in 2021, 2020 and 2019, the fair value of each reporting unit exceeded its carrying value, and accordingly, we did not record any goodwill impairment charges in 2021, 2020 or 2019.
Our reporting units include components of the Industrial Precision Solutions and the Advanced Technology Solutions segments.
Changes in the carrying amount of goodwill during 2021 by operating segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Precision Solutions
|
|
Advanced Technology Solutions
|
|
|
|
Total
|
Balance at October 31, 2020
|
$
|
415,862
|
|
|
$
|
1,297,492
|
|
|
|
|
$
|
1,713,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency effect
|
(842)
|
|
|
636
|
|
|
|
|
(206)
|
|
Balance at October 31, 2021
|
$
|
415,020
|
|
|
$
|
1,298,128
|
|
|
|
|
$
|
1,713,148
|
|
Changes in the carrying amount of goodwill during 2020 by operating segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Precision Solutions
|
|
Advanced Technology Solutions
|
|
|
|
Total
|
Balance at October 31, 2019
|
$
|
411,461
|
|
|
$
|
1,203,278
|
|
|
|
|
$
|
1,614,739
|
|
Acquisition
|
—
|
|
|
90,441
|
|
|
|
|
90,441
|
|
Other
|
(453)
|
|
|
—
|
|
|
|
|
(453)
|
|
Currency effect
|
4,854
|
|
|
3,773
|
|
|
|
|
8,627
|
|
Balance at October 31, 2020
|
$
|
415,862
|
|
|
$
|
1,297,492
|
|
|
|
|
$
|
1,713,354
|
|
Accumulated impairment losses, which were recorded in 2009, were $232,789 of which $229,173 related to the Advanced Technology Solutions segment and $3,616 related to the Industrial Precision Solutions segment.
The Other activity above reflects an allocation of goodwill to the disposal group classified as held for sale in 2020.
Notes to Consolidated Financial Statements — (Continued)
Information regarding intangible assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2021
|
|
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
Customer relationships
|
$
|
483,815
|
|
|
$
|
226,658
|
|
|
$
|
257,157
|
|
Patent/technology costs
|
154,267
|
|
|
89,299
|
|
|
64,968
|
|
Trade names
|
74,301
|
|
|
39,858
|
|
|
34,443
|
|
Noncompete agreements
|
9,896
|
|
|
9,099
|
|
|
797
|
|
Other
|
1,385
|
|
|
1,383
|
|
|
2
|
|
Total
|
$
|
723,664
|
|
|
$
|
366,297
|
|
|
$
|
357,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2020
|
|
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
Customer relationships
|
$
|
483,568
|
|
|
$
|
193,617
|
|
|
$
|
289,951
|
|
Patent/technology costs
|
153,555
|
|
|
76,934
|
|
|
76,621
|
|
Trade names
|
74,240
|
|
|
34,693
|
|
|
39,547
|
|
Noncompete agreements
|
9,908
|
|
|
8,444
|
|
|
1,464
|
|
Other
|
1,403
|
|
|
1,400
|
|
|
3
|
|
Total
|
$
|
722,674
|
|
|
$
|
315,088
|
|
|
$
|
407,586
|
|
Amortization expense for 2021, 2020 and 2019 was $50,551, $56,979 and $54,790, respectively.
Estimated amortization expense for each of the five succeeding years:
|
|
|
|
|
|
|
|
|
Year
|
|
Amounts
|
2022
|
|
$
|
46,696
|
|
2023
|
|
$
|
45,355
|
|
2024
|
|
$
|
39,784
|
|
2025
|
|
$
|
38,796
|
|
2026
|
|
$
|
37,530
|
|
Note 7 — Retirement, pension and other postretirement plans
Retirement plans — We have funded contributory retirement plans covering certain employees. Our contributions are primarily determined by the terms of the plans, subject to the limitation that they shall not exceed the amounts deductible for income tax purposes. We also sponsor unfunded contributory supplemental retirement plans for certain employees. Generally, benefits under these plans vest gradually over a period of approximately three years from date of employment, and are based on the employee’s contribution. The expense applicable to retirement plans for 2021, 2020 and 2019 was approximately $22,983, $20,265 and $22,573, respectively.
Pension plans — We have various pension plans covering a portion of our United States and international employees. Pension plan benefits are generally based on years of employment and, for salaried employees, the level of compensation. Actuarially determined amounts are contributed to United States plans to provide sufficient assets to meet future benefit payment requirements. We also sponsor an unfunded supplemental pension plan for certain employees. International subsidiaries fund their pension plans according to local requirements.
Notes to Consolidated Financial Statements — (Continued)
A reconciliation of the benefit obligations, plan assets, accrued benefit cost and the amount recognized in financial statements for pension plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
$
|
615,768
|
|
|
$
|
551,997
|
|
|
$
|
104,849
|
|
|
$
|
97,990
|
|
Service cost
|
22,555
|
|
|
20,635
|
|
|
2,120
|
|
|
2,099
|
|
Interest cost
|
13,652
|
|
|
15,824
|
|
|
887
|
|
|
1,025
|
|
Participant contributions
|
—
|
|
|
—
|
|
|
80
|
|
|
83
|
|
Amendments
|
—
|
|
|
—
|
|
|
15
|
|
|
—
|
|
Settlements
|
(9,016)
|
|
|
(4,992)
|
|
|
(714)
|
|
|
—
|
|
Curtailments
|
(2,436)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Foreign currency exchange rate change
|
—
|
|
|
—
|
|
|
1,024
|
|
|
2,814
|
|
Actuarial loss (gain)
|
4,561
|
|
|
47,788
|
|
|
(121)
|
|
|
2,729
|
|
Benefits paid
|
(17,813)
|
|
|
(15,484)
|
|
|
(2,091)
|
|
|
(1,891)
|
|
Benefit obligation at end of year
|
$
|
627,271
|
|
|
$
|
615,768
|
|
|
$
|
106,049
|
|
|
$
|
104,849
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
Beginning fair value of plan assets
|
$
|
510,250
|
|
|
$
|
448,931
|
|
|
$
|
45,476
|
|
|
$
|
39,640
|
|
Actual return on plan assets
|
62,063
|
|
|
41,712
|
|
|
243
|
|
|
3,697
|
|
Company contributions
|
94,105
|
|
|
40,083
|
|
|
3,318
|
|
|
3,365
|
|
Participant contributions
|
—
|
|
|
—
|
|
|
80
|
|
|
83
|
|
Settlements
|
(9,016)
|
|
|
(4,992)
|
|
|
(714)
|
|
|
—
|
|
Foreign currency exchange rate change
|
—
|
|
|
—
|
|
|
962
|
|
|
582
|
|
Benefits paid
|
(17,813)
|
|
|
(15,484)
|
|
|
(2,091)
|
|
|
(1,891)
|
|
Ending fair value of plan assets
|
$
|
639,589
|
|
|
$
|
510,250
|
|
|
$
|
47,274
|
|
|
$
|
45,476
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
$
|
12,318
|
|
|
$
|
(105,518)
|
|
|
$
|
(58,775)
|
|
|
$
|
(59,373)
|
|
|
|
|
|
|
|
|
|
Amounts recognized in financial statements:
|
|
|
|
|
|
|
|
Noncurrent asset
|
$
|
30,840
|
|
|
$
|
3,162
|
|
|
$
|
4,086
|
|
|
$
|
3,321
|
|
Accrued benefit liability
|
(799)
|
|
|
(5,211)
|
|
|
—
|
|
|
(634)
|
|
Long-term pension obligations
|
(17,723)
|
|
|
(103,469)
|
|
|
(62,861)
|
|
|
(62,060)
|
|
Total amount recognized in financial statements
|
$
|
12,318
|
|
|
$
|
(105,518)
|
|
|
$
|
(58,775)
|
|
|
$
|
(59,373)
|
|
The net actuarial loss included in the projected benefit obligation for the United States pension plans for 2021 was primarily due to updated census data partially offset by gains due to changes in the discount rates. The net actuarial loss included in the projected benefit obligation for 2020 was primarily due to lower discount rates and updated census data and assumptions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Amounts recognized in accumulated other comprehensive (gain) loss:
|
|
|
|
|
|
|
|
Net actuarial loss
|
$
|
142,070
|
|
|
$
|
192,593
|
|
|
$
|
30,544
|
|
|
$
|
32,097
|
|
Prior service cost (credit)
|
48
|
|
|
(16)
|
|
|
(1,808)
|
|
|
(2,137)
|
|
Accumulated other comprehensive loss
|
$
|
142,118
|
|
|
$
|
192,577
|
|
|
$
|
28,736
|
|
|
$
|
29,960
|
|
|
|
|
|
|
|
|
|
Notes to Consolidated Financial Statements — (Continued)
The following table summarizes the changes in accumulated other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Balance at beginning of year
|
$
|
192,577
|
|
|
$
|
178,290
|
|
|
$
|
29,960
|
|
|
$
|
31,484
|
|
Net (gain) loss arising during the year
|
(29,091)
|
|
|
30,743
|
|
|
1,220
|
|
|
305
|
|
Prior service cost arising during the year
|
—
|
|
|
—
|
|
|
15
|
|
|
—
|
|
Net gain recognized during the year
|
(14,885)
|
|
|
(14,032)
|
|
|
(3,144)
|
|
|
(2,972)
|
|
Prior service credit recognized during the year
|
64
|
|
|
84
|
|
|
303
|
|
|
290
|
|
Settlement loss
|
(4,111)
|
|
|
(2,508)
|
|
|
(32)
|
|
|
—
|
|
Curtailment
|
(2,436)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Exchange rate effect during the year
|
—
|
|
|
—
|
|
|
414
|
|
|
853
|
|
Balance at end of year
|
$
|
142,118
|
|
|
$
|
192,577
|
|
|
$
|
28,736
|
|
|
$
|
29,960
|
|
Information regarding the funded status of the Company's plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
For plans with accumulated benefit obligation in excess of plan assets:
|
|
|
|
|
|
|
|
Accumulated benefit obligation
|
$
|
16,182
|
|
|
$
|
508,671
|
|
|
$
|
85,559
|
|
|
$
|
85,189
|
|
Fair value of plan assets
|
—
|
|
|
444,723
|
|
|
32,306
|
|
|
30,797
|
|
For plans with projected benefit obligation in excess of plan assets:
|
|
|
|
|
|
|
|
Projected benefit obligation
|
18,522
|
|
|
553,403
|
|
|
95,221
|
|
|
93,491
|
|
Fair value of plan assets
|
—
|
|
|
444,723
|
|
|
32,360
|
|
|
30,797
|
|
Net periodic pension costs include the following components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2019
|
|
2021
|
|
2020
|
|
2019
|
Service cost
|
$
|
22,555
|
|
|
$
|
20,635
|
|
|
$
|
14,587
|
|
|
$
|
2,120
|
|
|
$
|
2,099
|
|
|
$
|
1,933
|
|
Interest cost
|
13,652
|
|
|
15,824
|
|
|
18,304
|
|
|
887
|
|
|
1,025
|
|
|
1,670
|
|
Expected return on plan assets
|
(28,410)
|
|
|
(24,667)
|
|
|
(23,341)
|
|
|
(1,585)
|
|
|
(1,273)
|
|
|
(1,592)
|
|
Amortization of prior service credit
|
(64)
|
|
|
(84)
|
|
|
(61)
|
|
|
(303)
|
|
|
(290)
|
|
|
(303)
|
|
Amortization of net actuarial loss
|
14,885
|
|
|
14,032
|
|
|
6,702
|
|
|
3,144
|
|
|
2,972
|
|
|
1,696
|
|
Settlement loss
|
4,111
|
|
|
2,508
|
|
|
—
|
|
|
32
|
|
|
—
|
|
|
470
|
|
Total benefit cost
|
$
|
26,729
|
|
|
$
|
28,248
|
|
|
$
|
16,191
|
|
|
$
|
4,295
|
|
|
$
|
4,533
|
|
|
$
|
3,874
|
|
Net periodic pension cost for 2021, 2020 and 2019 included settlement losses of $4,143, $2,508 and $470, respectively, due to lump sum retirement payments.
The components of net periodic pension cost other than service cost are included in Other – net in our Consolidated Statements of Income.
Notes to Consolidated Financial Statements — (Continued)
The weighted average assumptions used in the valuation of pension benefits were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2019
|
|
2021
|
|
2020
|
|
2019
|
Assumptions used to determine benefit obligations at October 31:
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
3.02
|
%
|
|
2.85
|
%
|
|
3.25
|
%
|
|
1.30
|
%
|
|
1.01
|
%
|
|
1.26
|
%
|
Rate of compensation increase
|
4.00
|
|
|
4.00
|
|
|
4.00
|
|
|
2.90
|
|
|
2.69
|
|
|
3.12
|
|
Assumptions used to determine net benefit costs for the years ended October 31:
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate - benefit obligation
|
2.85
|
|
|
3.25
|
|
|
4.53
|
|
|
1.01
|
|
|
1.26
|
|
|
2.14
|
|
Discount rate - service cost
|
3.30
|
|
|
3.56
|
|
|
4.70
|
|
|
0.93
|
|
|
1.12
|
|
|
1.82
|
|
Discount rate - interest cost
|
2.10
|
|
|
2.78
|
|
|
4.15
|
|
|
0.80
|
|
|
1.05
|
|
|
1.90
|
|
Expected return on plan assets
|
5.75
|
|
|
5.75
|
|
|
6.00
|
|
|
3.31
|
|
|
3.22
|
|
|
3.96
|
|
Rate of compensation increase
|
4.00
|
|
|
4.00
|
|
|
3.90
|
|
|
2.69
|
|
|
3.12
|
|
|
3.12
|
|
The amortization of prior service cost is determined using a straight-line amortization of the cost over the average remaining service period of employees expected to receive benefits under the plans.
The discount rate reflects the current rate at which pension liabilities could be effectively settled at the end of the year. The discount rate used considers a yield derived from matching projected pension payments with maturities of a portfolio of available bonds that receive the highest rating given from a recognized investments ratings agency. The changes in the discount rates in 2021, 2020, and 2019 are due to changes in yields for these types of investments as a result of the economic environment.
In determining the expected return on plan assets using the calculated value of plan assets, we consider both historical performance and an estimate of future long-term rates of return on assets similar to those in our plans. We consult with and consider the opinions of financial and other professionals in developing appropriate return assumptions. The rate of compensation increase is based on management’s estimates using historical experience and expected increases in rates.
The international plans include a cash balance plan with promised interest crediting rates. The weighted average crediting rates were 0.50%, 0.40% and 0.60% for 2021, 2020 and 2019.
Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when they exceed the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations. Gains or losses within the corridor remain in other comprehensive income and are retested in subsequent measurements. Gains or losses outside of the corridor are subject to amortization over an average employee future service period that differs by plan. If substantially all of the plan’s participants are no longer actively accruing benefits, the average life expectancy is used.
The allocation of pension plan assets as of October 31, 2021 and 2020 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Asset Category
|
|
|
|
|
|
|
|
Equity securities
|
13
|
%
|
|
11
|
%
|
|
—
|
%
|
|
—
|
%
|
Debt securities
|
46
|
|
|
49
|
|
|
—
|
|
|
—
|
|
Insurance contracts
|
—
|
|
|
—
|
|
|
51
|
|
|
54
|
|
Pooled investment funds
|
41
|
|
|
39
|
|
|
48
|
|
|
44
|
|
Other
|
—
|
|
|
1
|
|
|
1
|
|
|
2
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
Our investment objective for defined benefit plan assets is to meet the plans’ benefit obligations, while minimizing the potential for future required plan contributions.
Notes to Consolidated Financial Statements — (Continued)
Our United States plans comprise 93 percent of the Company's worldwide pension assets. In general, the investment strategies focus on asset class diversification, liquidity to meet benefit payments and an appropriate balance of long-term investment return and risk. Target ranges for asset allocations are determined by dynamically matching the actuarial projections of the plans’ future liabilities and benefit payments with expected long-term rates of return on the assets, taking into account investment return volatility and correlations across asset classes. For 2021, the target in “return-seeking assets” is 30 percent and 70 percent in longer duration fixed income assets. Plan assets are diversified across multiple investment managers and are invested in liquid funds that are selected to track broad market indices. Investment risk is carefully controlled with plan assets rebalanced to target allocations on a periodic basis and continual monitoring of investment managers’ performance relative to the guidelines established with each investment manager.
Our international plans comprise 7 percent of the Company's worldwide pension assets. Asset allocations are developed on a country-specific basis. Our investment strategy is to cover pension obligations with insurance contracts or to employ independent managers to invest the assets.
The fair values of our pension plan assets at October 31, 2021 by asset category are in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
Cash
|
$
|
1,467
|
|
|
$
|
1,467
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
519
|
|
|
$
|
519
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Money market funds
|
4,495
|
|
|
4,495
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic materials
|
2,038
|
|
|
2,038
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Consumer goods
|
4,360
|
|
|
4,360
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Financial
|
3,753
|
|
|
3,753
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Healthcare
|
4,864
|
|
|
4,864
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Industrial goods
|
3,640
|
|
|
3,640
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Technology
|
5,080
|
|
|
5,080
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Utilities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Mutual funds
|
52,319
|
|
|
52,319
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Fixed income securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government
|
89,614
|
|
|
4,024
|
|
|
85,590
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Corporate
|
194,793
|
|
|
—
|
|
|
194,793
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Other
|
9,619
|
|
|
—
|
|
|
9,619
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Other types of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance contracts
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23,993
|
|
|
—
|
|
|
—
|
|
|
23,993
|
|
Other
|
1,494
|
|
|
1,494
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total investments in the fair value hierarchy
|
$
|
377,536
|
|
|
$
|
87,534
|
|
|
$
|
290,002
|
|
|
$
|
—
|
|
|
$
|
24,512
|
|
|
$
|
519
|
|
|
$
|
—
|
|
|
$
|
23,993
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments measured at Net Asset Value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate collective funds
|
44,056
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
Pooled investment funds
|
217,997
|
|
|
|
|
|
|
|
|
22,762
|
|
|
|
|
|
|
|
Total Investments at Fair Value
|
$
|
639,589
|
|
|
|
|
|
|
|
|
$
|
47,274
|
|
|
|
|
|
|
|
Notes to Consolidated Financial Statements — (Continued)
The fair values of our pension plan assets at October 31, 2020 by asset category are in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
Cash
|
$
|
1,331
|
|
|
$
|
1,331
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
759
|
|
|
$
|
759
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Money market funds
|
5,059
|
|
|
5,059
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic materials
|
1,750
|
|
|
1,750
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Consumer goods
|
5,024
|
|
|
5,024
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Financial
|
4,745
|
|
|
4,745
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Healthcare
|
4,518
|
|
|
4,518
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Industrial goods
|
3,588
|
|
|
3,588
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Technology
|
5,706
|
|
|
5,706
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Utilities
|
685
|
|
|
685
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Mutual funds
|
24,266
|
|
|
24,266
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Fixed income securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government
|
71,855
|
|
|
8,267
|
|
|
63,588
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Corporate
|
173,046
|
|
|
—
|
|
|
173,046
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Other
|
6,673
|
|
|
—
|
|
|
6,673
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Other types of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance contracts
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24,496
|
|
|
—
|
|
|
—
|
|
|
24,496
|
|
Other
|
845
|
|
|
845
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total investments in the fair value hierarchy
|
$
|
309,091
|
|
|
$
|
65,784
|
|
|
$
|
243,307
|
|
|
$
|
—
|
|
|
$
|
25,255
|
|
|
$
|
759
|
|
|
$
|
—
|
|
|
$
|
24,496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments measured at Net Asset Value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate collective funds
|
38,996
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
Pooled investment funds
|
162,163
|
|
|
|
|
|
|
|
|
20,221
|
|
|
|
|
|
|
|
Total Investments at Fair Value
|
$
|
510,250
|
|
|
|
|
|
|
|
|
$
|
45,476
|
|
|
|
|
|
|
|
These investment funds did not own a significant number of shares of Nordson Corporation common stock for any year presented.
The inputs and methodology used to measure fair value of plan assets are consistent with those described in Note 12. Following are the valuation methodologies used to measure these assets:
•Money market funds - Money market funds are public investment vehicles that are valued with a net asset value of one dollar. This is a quoted price in an active market and is classified as Level 1.
•Equity securities - Common stocks and mutual funds are valued at the closing price reported on the active market on which the individual securities are traded and are classified as Level 1.
•Fixed income securities - U.S. Treasury bills reflect the closing price on the active market in which the securities are traded and are classified as Level 1. Securities of U.S. agencies are valued using bid evaluations and are classified as Level 2. Corporate fixed income securities are valued using evaluated prices, such as dealer quotes, bids and offers and are therefore classified as Level 2.
•Insurance contracts - Insurance contracts are investments with various insurance companies. The contract value represents the best estimate of fair value. These contracts do not hold any specific assets. These investments are classified as Level 3.
•Real estate collective funds – These funds are valued using the net asset value of the underlying properties. Net asset value is calculated using a combination of key inputs, such as revenue and expense growth rates, terminal capitalization rates and discount rates.
•Pooled investment funds - These are public investment vehicles valued using the net asset value. The net asset value is based on the value of the assets owned by the plan, less liabilities. These investments are not quoted on an active exchange.
Notes to Consolidated Financial Statements — (Continued)
The following tables present an analysis of changes during the years ended October 31, 2021 and 2020 in Level 3 plan assets, by plan asset class, for U.S. and international pension plans using significant unobservable inputs to measure fair value:
|
|
|
|
|
|
|
|
|
Fair Value Measurements
Using Significant Unobservable
Inputs (Level 3)
|
|
Insurance
contracts
|
|
|
Beginning balance at October 31, 2020
|
$
|
24,496
|
|
|
|
Actual return on plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
Purchases
|
1,441
|
|
|
|
Sales
|
(541)
|
|
|
|
Settlements
|
(714)
|
|
|
|
Unrealized losses
|
(440)
|
|
|
|
Foreign currency translation
|
(249)
|
|
|
|
Ending balance at October 31, 2021
|
$
|
23,993
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements
Using Significant Unobservable
Inputs (Level 3)
|
|
Insurance
contracts
|
|
|
Beginning balance at October 31, 2019
|
$
|
21,245
|
|
|
|
Actual return on plan assets:
|
|
|
|
Assets held, end of year
|
1,739
|
|
|
|
|
|
|
|
Purchases
|
2,462
|
|
|
|
Sales
|
(1,495)
|
|
|
|
Foreign currency translation
|
545
|
|
|
|
Ending balance at October 31, 2020
|
$
|
24,496
|
|
|
|
Contributions to pension plans in 2022 are estimated to be approximately $4,121.
Retiree pension benefit payments, which include expected future service, are anticipated to be paid as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
United States
|
|
International
|
2022
|
|
$
|
20,460
|
|
|
$
|
2,860
|
|
2023
|
|
21,953
|
|
|
2,826
|
|
2024
|
|
23,331
|
|
|
3,153
|
|
2025
|
|
25,088
|
|
|
3,395
|
|
2026
|
|
26,570
|
|
|
5,458
|
|
2026-2030
|
|
156,178
|
|
|
19,725
|
|
Other postretirement plans - We sponsor an unfunded postretirement health care benefit plan covering certain of our United States employees. Employees hired after January 1, 2002, are not eligible to participate in this plan. For eligible retirees under the age of 65 who enroll in the plan, the plan is contributory in nature, with retiree contributions in the form of premiums that are adjusted annually. For eligible retirees age 65 and older who enroll in the plan, the plan delivers a benefit in the form of a Health Reimbursement Account (HRA), which retirees use for eligible reimbursable expenses, including premiums paid for purchase of a Medicare supplement plan or other out-of-pocket medical expenses such as deductibles or co-pays.
Notes to Consolidated Financial Statements — (Continued)
A reconciliation of the benefit obligations, accrued benefit cost and the amount recognized in financial statements for other postretirement plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
$
|
87,645
|
|
|
$
|
88,660
|
|
|
$
|
445
|
|
|
$
|
454
|
|
Service cost
|
778
|
|
|
666
|
|
|
15
|
|
|
15
|
|
Interest cost
|
1,805
|
|
|
2,345
|
|
|
12
|
|
|
13
|
|
Participant contributions
|
722
|
|
|
611
|
|
|
—
|
|
|
—
|
|
Foreign currency exchange rate change
|
—
|
|
|
—
|
|
|
33
|
|
|
(5)
|
|
Actuarial gain
|
(2,799)
|
|
|
(2,024)
|
|
|
(83)
|
|
|
(26)
|
|
Benefits paid
|
(2,861)
|
|
|
(2,613)
|
|
|
(6)
|
|
|
(6)
|
|
Benefit obligation at end of year
|
$
|
85,290
|
|
|
$
|
87,645
|
|
|
$
|
416
|
|
|
$
|
445
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
Beginning fair value of plan assets
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Company contributions
|
2,139
|
|
|
2,002
|
|
|
6
|
|
|
6
|
|
Participant contributions
|
722
|
|
|
611
|
|
|
—
|
|
|
—
|
|
Benefits paid
|
(2,861)
|
|
|
(2,613)
|
|
|
(6)
|
|
|
(6)
|
|
Ending fair value of plan assets
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
$
|
(85,290)
|
|
|
$
|
(87,645)
|
|
|
$
|
(416)
|
|
|
$
|
(445)
|
|
|
|
|
|
|
|
|
|
Amounts recognized in financial statements:
|
|
|
|
|
|
|
|
Accrued benefit liability
|
$
|
(3,048)
|
|
|
$
|
(2,835)
|
|
|
$
|
(6)
|
|
|
$
|
(6)
|
|
Long-term postretirement obligations
|
(82,242)
|
|
|
(84,810)
|
|
|
(410)
|
|
|
(439)
|
|
Total amount recognized in financial statements
|
$
|
(85,290)
|
|
|
$
|
(87,645)
|
|
|
$
|
(416)
|
|
|
$
|
(445)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Amounts recognized in accumulated other comprehensive (gain) loss:
|
|
|
|
|
|
|
|
Net actuarial (gain) loss
|
$
|
21,456
|
|
|
$
|
25,614
|
|
|
$
|
(543)
|
|
|
$
|
(466)
|
|
Prior service credit
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Accumulated other comprehensive (gain) loss
|
$
|
21,456
|
|
|
$
|
25,614
|
|
|
$
|
(543)
|
|
|
$
|
(466)
|
|
Notes to Consolidated Financial Statements — (Continued)
The following table summarizes the changes in accumulated other comprehensive (gain) loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Balance at beginning of year
|
$
|
25,614
|
|
|
$
|
28,976
|
|
|
$
|
(466)
|
|
|
$
|
(482)
|
|
Net gain arising during the year
|
(2,799)
|
|
|
(2,024)
|
|
|
(83)
|
|
|
(26)
|
|
Net gain (loss) recognized during the year
|
(1,359)
|
|
|
(1,355)
|
|
|
41
|
|
|
36
|
|
Prior service credit recognized during the year
|
—
|
|
|
17
|
|
|
—
|
|
|
—
|
|
Exchange rate effect during the year
|
—
|
|
|
—
|
|
|
(35)
|
|
|
6
|
|
Balance at end of year
|
$
|
21,456
|
|
|
$
|
25,614
|
|
|
$
|
(543)
|
|
|
$
|
(466)
|
|
Net postretirement benefit costs include the following components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2019
|
|
2021
|
|
2020
|
|
2019
|
Service cost
|
$
|
778
|
|
|
$
|
666
|
|
|
$
|
545
|
|
|
$
|
15
|
|
|
$
|
15
|
|
|
$
|
16
|
|
Interest cost
|
1,805
|
|
|
2,345
|
|
|
2,984
|
|
|
12
|
|
|
13
|
|
|
19
|
|
Amortization of prior service credit
|
—
|
|
|
(17)
|
|
|
(26)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Amortization of net actuarial (gain) loss
|
1,359
|
|
|
1,355
|
|
|
634
|
|
|
(41)
|
|
|
(36)
|
|
|
(28)
|
|
Total benefit cost (credit)
|
$
|
3,942
|
|
|
$
|
4,349
|
|
|
$
|
4,137
|
|
|
$
|
(14)
|
|
|
$
|
(8)
|
|
|
$
|
7
|
|
The components of net postretirement benefit cost other than service cost are included in Other – net in our Consolidated Statements of Income.
The weighted average assumptions used in the valuation of postretirement benefits were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
International
|
|
2021
|
|
2020
|
|
2019
|
|
2021
|
|
2020
|
|
2019
|
Assumptions used to determine benefit obligations at October 31:
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
2.98
|
%
|
|
2.84
|
%
|
|
3.27
|
%
|
|
3.43
|
%
|
|
2.94
|
%
|
|
3.03
|
%
|
Health care cost trend rate
|
3.34
|
|
|
3.40
|
|
|
3.62
|
|
|
4.43
|
|
|
4.22
|
|
|
4.00
|
|
Rate to which health care cost trend rate is assumed to incline/decline (ultimate trend rate)
|
3.15
|
|
|
3.17
|
|
|
3.24
|
|
|
4.05
|
|
|
4.05
|
|
|
4.05
|
|
Year the rate reaches the ultimate trend rate
|
2031
|
|
2026
|
|
2026
|
|
2040
|
|
2040
|
|
2040
|
Assumption used to determine net benefit costs for the years ended October 31:
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate benefit obligation
|
2.84
|
%
|
|
3.27
|
%
|
|
4.56
|
%
|
|
2.94
|
%
|
|
3.03
|
%
|
|
3.88
|
%
|
Discount rate service cost
|
3.44
|
|
|
3.61
|
|
|
4.77
|
|
|
3.00
|
|
|
3.05
|
|
|
3.90
|
|
Discount rate interest cost
|
2.08
|
|
|
2.79
|
|
|
4.18
|
|
|
2.60
|
|
|
2.88
|
|
|
3.80
|
|
The weighted average health care trend rates reflect expected increases in the Company’s portion of the obligation.
Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when they exceed the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations. Gains or losses outside of the corridor are subject to amortization over an average employee future service period that differs by plan. If substantially all of the plan’s participants are no longer actively accruing benefits, the average life expectancy is used.
Contributions to postretirement plans in 2022 are estimated to be approximately $3,054.
Notes to Consolidated Financial Statements — (Continued)
Retiree postretirement benefit payments are anticipated to be paid as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
United States
|
|
International
|
2022
|
$
|
3,048
|
|
|
$
|
6
|
|
2023
|
3,227
|
|
|
6
|
|
2024
|
3,423
|
|
|
6
|
|
2025
|
3,593
|
|
|
6
|
|
2026
|
3,753
|
|
|
9
|
|
2026-2030
|
20,376
|
|
|
54
|
|
Note 8 — Income taxes
Income tax expense includes the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Current:
|
|
|
|
|
|
U.S. federal
|
$
|
41,983
|
|
|
$
|
19,265
|
|
|
$
|
40,012
|
|
State and local
|
4,429
|
|
|
984
|
|
|
3,429
|
|
Foreign
|
69,325
|
|
|
45,657
|
|
|
51,590
|
|
Total current
|
115,737
|
|
|
65,906
|
|
|
95,031
|
|
Deferred:
|
|
|
|
|
|
U.S. federal
|
6,631
|
|
|
(10,143)
|
|
|
1,470
|
|
State and local
|
1,470
|
|
|
(1,023)
|
|
|
633
|
|
Foreign
|
(4,030)
|
|
|
(2,790)
|
|
|
(3,121)
|
|
Total deferred
|
4,071
|
|
|
(13,956)
|
|
|
(1,018)
|
|
|
$
|
119,808
|
|
|
$
|
51,950
|
|
|
$
|
94,013
|
|
Earnings before income taxes of domestic operations, which are calculated after intercompany profit eliminations, were $287,409, $120,054 and $222,435 in 2021, 2020 and 2019, respectively.
Our income tax provision for 2021 included a tax benefit of $5,982 due to our share-based payment transactions.
Our income tax provision for 2020 included a tax benefit of $15,661 due to our share-based payment transactions. Income before taxes in 2020 included a non-cash, assets held for sale impairment charge of $87,371 related to our commitment to sell our screws and barrels product line within the Adhesives reporting unit under our Industrial Precision Solutions segment and the tax benefit of the impairment was $15,254. A portion of the impairment charge did not have related tax benefits.
Our income tax provision for 2019 included a provisional tax benefit of $4,866 to reflect the adjustment to the provisional amounts recognized in 2018 due to changes in interpretations and assumptions and the finalization of estimates related to the U.S. Tax Cuts and Jobs Act (the "Act"). We are paying the transition tax in installments over the eight-year period allowable under the Act. The remaining transition tax is included in other long-term liabilities in the Consolidated Balance Sheet at October 31, 2021.
Other provisions of the Act became effective for us in 2019. The Foreign-Derived Intangible Income provision generates a deduction against our U.S. taxable income for U.S. earnings derived offshore that utilize intangibles held in the U.S. Conversely, the Global Intangible Low-Taxed Income (“GILTI”) provision requires us to be subject to U.S. taxation on a portion of our foreign subsidiary earnings that exceed an allowable return. We elected to treat any GILTI inclusion as a period expense in the year incurred.
Notes to Consolidated Financial Statements — (Continued)
A reconciliation of the U.S. statutory federal rate to the worldwide consolidated effective tax rate follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Statutory federal income tax rate
|
21.00
|
%
|
|
21.00
|
%
|
|
21.00
|
%
|
Transition tax
|
—
|
|
|
—
|
|
|
1.46
|
|
|
|
|
|
|
|
Share-based and other compensation
|
(0.30)
|
|
|
(4.15)
|
|
|
(0.55)
|
|
|
|
|
|
|
|
Foreign tax rate variances, net of foreign tax credits
|
0.92
|
|
|
1.51
|
|
|
1.16
|
|
State and local taxes, net of federal income tax benefit
|
0.81
|
|
|
(0.01)
|
|
|
0.74
|
|
Amounts related to prior years
|
(0.18)
|
|
|
(0.04)
|
|
|
(0.55)
|
|
Foreign-Derived Intangible Income Deduction
|
(1.19)
|
|
|
(0.95)
|
|
|
(1.51)
|
|
Global Intangible Low-Taxed Income net of foreign tax credits
|
0.44
|
|
|
0.97
|
|
|
0.85
|
|
Other – net
|
(0.63)
|
|
|
(1.10)
|
|
|
(0.79)
|
|
Effective tax rate
|
20.87
|
%
|
|
17.23
|
%
|
|
21.81
|
%
|
Earnings before income taxes of international operations, which are calculated before intercompany profit elimination entries, were $286,767, $181,435 and $208,669 in 2021, 2020 and 2019, respectively. Deferred income taxes are not provided on undistributed earnings of international subsidiaries that are intended to be permanently invested in their operations. These undistributed earnings represent the post-income tax earnings under U.S. GAAP not adjusted for previously taxed income which aggregated approximately $1,255,112 and $1,045,389 at October 31, 2021 and 2020, respectively. Should these earnings be distributed, applicable foreign tax credits, distributions of previously taxed income, and utilization of other attributes would substantially offset taxes due upon the distribution. It is not practical to estimate the amount of additional taxes that might be payable on these basis differences because of the multiple methods by which these differences could reverse and the impact of withholding, U.S. state and local taxes and currency translation considerations.
At October 31, 2021 and 2020, total unrecognized tax benefits were $3,720 and $6,717, respectively. The amounts that, if recognized, would impact the effective tax rate were $3,567 and $5,998 at October 31, 2021 and 2020, respectively. During 2021, unrecognized tax benefits related primarily to domestic positions and, as recognized, a substantial portion of the gross unrecognized tax benefits were offset against assets recorded in the Consolidated Balance Sheet. A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2021, 2020 and 2019 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Balance at beginning of year
|
$
|
6,717
|
|
|
$
|
2,909
|
|
|
$
|
2,891
|
|
Additions based on tax positions related to the current year
|
370
|
|
|
370
|
|
|
370
|
|
Additions for tax positions of prior years
|
—
|
|
|
4,068
|
|
|
547
|
|
Reductions for tax positions of prior years
|
(350)
|
|
|
—
|
|
|
—
|
|
Settlements
|
—
|
|
|
(137)
|
|
|
—
|
|
Lapse of statute of limitations
|
(3,017)
|
|
|
(493)
|
|
|
(899)
|
|
Balance at end of year
|
$
|
3,720
|
|
|
$
|
6,717
|
|
|
$
|
2,909
|
|
At October 31, 2021 and 2020, we had accrued interest and penalty expense related to unrecognized tax benefits of $859 and $2,179, respectively. We include interest accrued related to unrecognized tax benefits in interest expense. Penalties, if incurred, would be recognized as other income (expense).
We are subject to United States Federal income tax as well as income taxes in numerous state and foreign jurisdictions. We are subject to examination in the U.S. by the Internal Revenue Service (IRS) for the 2018 through 2021 tax years; tax years prior to the 2018 year are closed to further examination by the IRS. Generally, major state and foreign jurisdiction tax years remain open to examination for tax years after 2015. Within the next twelve months, it is reasonably possible that certain statute of limitations periods would expire, which could result in a minimal decrease in our unrecognized tax benefits.
Notes to Consolidated Financial Statements — (Continued)
Significant components of deferred tax assets and liabilities are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
Deferred tax assets:
|
|
|
|
Employee benefits
|
$
|
39,798
|
|
|
$
|
70,838
|
|
Other accruals not currently deductible for taxes
|
17,499
|
|
|
16,207
|
|
Tax credit and loss carryforwards
|
19,269
|
|
|
20,268
|
|
Inventory adjustments
|
6,924
|
|
|
8,757
|
|
Total deferred tax assets
|
83,490
|
|
|
116,070
|
|
Valuation allowance
|
(14,141)
|
|
|
(22,233)
|
|
Total deferred tax assets
|
69,349
|
|
|
93,837
|
|
Deferred tax liabilities:
|
|
|
|
Depreciation and amortization
|
145,494
|
|
|
150,591
|
|
Other - net
|
941
|
|
|
410
|
|
Total deferred tax liabilities
|
146,435
|
|
|
151,001
|
|
Net deferred tax liabilities
|
$
|
(77,086)
|
|
|
$
|
(57,164)
|
|
At October 31, 2021, we had $11,128 of tax credit carryforwards, $3,543 of which expires in 2028-2031 and $7,585 of which has an indefinite carryforward period. We also had $34,680 of state operating loss carryforwards, $19,525 of foreign operating loss carryforwards, and a $20,149 capital loss carryforward, of which $57,758 will expire in 2022 through 2039, and $16,596 of which has an indefinite carryforward period. The net change in the valuation allowance was a decrease of $8,092 in 2021 and an increase of $6,932 in 2020. The valuation allowance of $14,141 at October 31, 2021, related primarily to tax credits and loss carryforwards that may expire before being realized. We continue to assess the need for valuation allowances against deferred tax assets based on determinations of whether it is more likely than not that deferred tax benefits will be realized.
Note 9 — Bank lines of credit
Bank lines of credit are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
Maximum borrowings available under bank lines of credit (all foreign banks)
|
$
|
60,627
|
|
|
$
|
74,766
|
|
|
|
|
|
|
|
|
|
Unused bank lines of credit
|
$
|
57,082
|
|
|
$
|
74,766
|
|
Note 10 — Long-term debt
A summary of long-term debt is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
|
|
Notes Payable
|
$
|
3,545
|
|
|
$
|
—
|
|
Senior notes, due 2022-2025
|
79,000
|
|
|
109,900
|
|
Senior notes, due 2022-2027
|
78,572
|
|
|
85,714
|
|
Senior notes, due 2023-2030
|
350,000
|
|
|
350,000
|
|
Term loan
|
—
|
|
|
255,000
|
|
Euro loan, due 2023
|
306,358
|
|
|
308,642
|
|
|
817,475
|
|
|
1,109,256
|
|
Less current maturities
|
34,188
|
|
|
38,043
|
|
Less unamortized debt issuance costs
|
1,578
|
|
|
3,261
|
|
Long-term maturities
|
$
|
781,709
|
|
|
$
|
1,067,952
|
|
Revolving credit agreement — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our existing syndicated revolving credit agreement that was scheduled to expire in February 2020. This facility has a five-year term and includes a $75,000 subfacility for swing-line loans. It expires in April 2024. At October 31, 2021 and October 31, 2020, we had no balances outstanding under this facility.
Senior notes, due 2022-2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies had a remaining weighted-average life of 1.95 years. The weighted-average interest rate at October 31, 2021 was 3.10 percent.
Notes to Consolidated Financial Statements — (Continued)
Senior notes, due 2022-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies had a remaining weighted-average life of 3.20 years. The weighted-average interest rate at October 31, 2021 was 3.08 percent.
Senior notes, due 2023-2030 — These unsecured fixed-rate notes entered in 2018 with a group of insurance companies had a remaining weighted-average life of 4.04 years. The weighted-average interest rate at October 31, 2021 was 3.90 percent.
Term loan — In April 2019, we amended, restated and extended the term of our existing $605,000 term loan facility with a group of banks. The interest rate is variable based upon the LIBOR rate. At October 31, 2021, there were no outstanding loans under this facility.
Euro loan, due 2023 — In March 2020 we amended, restated and extended the term of our existing term loan facility with Bank of America Merrill Lynch International Limited. The interest rate is variable based on the EURIBOR rate. The term loan facility provides for the following term loans due in two tranches: €115,000 is due in March 2023 and an additional €150,000 that was drawn down in March 2020 is due in March 2023. The weighted average interest rate at October 31, 2021 was 0.71 percent.
We were in compliance with all covenants at October 31, 2021 and the amount we could borrow would not have been limited by any debt covenants.
Annual maturities — The annual maturities of long-term debt for the five years subsequent to October 31, 2021, are as follows: $30,643 in 2022; $437,001 in 2023; $110,643 in 2024; $85,643 in 2025 and $50,000 in 2026.
Note 11 — Leases
We review new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, we have recognized those amounts as part of the right-of-use assets and lease liabilities. We combine lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, we use an incremental borrowing rate (IBR) based on information available at the lease commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. We calculate the IBR based on a bond yield curve which considers secured borrowing rates based on our credit rating and current economic environment, as well as other publicly available data.
We lease certain manufacturing facilities, warehouse space, machinery and equipment, and vehicles. We often have options to renew lease terms for buildings and other assets. We evaluate renewal and termination options at the lease commencement date to determine if we are reasonably certain to exercise the option on the basis of economic factors. Leases with an initial term of 12 months or less (short-term leases) are not recorded on the Consolidated Balance Sheet. Lease expense for operating leases is recognized on a straight-line basis over the lease term, with variable lease payments recognized in the period those payments occur. Variable payments for leases primarily relate to future rates or amounts, miles, or other quantifiable usage factors which are not determinable at the time the lease agreement commences. Finance lease assets are recorded in Property, plant, and equipment – net on the Consolidated Balance Sheet with related amortization recorded in depreciation expense on the Consolidated Statement of Cash Flows. As of October 31, 2021, we had no material leases that had yet to commence.
Additional lease information is summarized below for the twelve months ended October 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2021
|
|
October 31, 2020
|
|
Finance Leases
|
|
Operating Leases
|
|
Finance Leases
|
|
Operating Leases
|
Amortization of right of use assets
|
$
|
6,929
|
|
|
|
|
$
|
7,087
|
|
|
|
Interest
|
373
|
|
|
|
|
350
|
|
|
|
Lease cost (1)
|
7,302
|
|
|
$
|
20,176
|
|
|
7,437
|
|
|
$
|
21,489
|
|
Short-term and variable lease cost (1)
|
1,445
|
|
|
2,938
|
|
|
1,478
|
|
|
3,011
|
|
Total lease cost
|
$
|
8,747
|
|
|
$
|
23,114
|
|
|
$
|
8,915
|
|
|
$
|
24,500
|
|
(1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income.
Notes to Consolidated Financial Statements — (Continued)
Supplemental cash flow information is summarized below for the twelve months ended October 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance Leases
|
|
Operating Leases
|
Cash outflows for leases
|
$
|
6,624
|
|
$
|
20,231
|
Weighted average remaining lease term (years)
|
8.29
|
|
9.88
|
Weighted average discount rate
|
2.13%
|
|
1.68%
|
The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the Consolidated Balance Sheet as of October 31, 2021. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year:
|
|
Finance Leases
|
|
Operating Leases
|
2022
|
|
$
|
6,162
|
|
|
$
|
18,942
|
|
2023
|
|
4,454
|
|
|
16,071
|
|
2024
|
|
2,498
|
|
|
13,825
|
|
2025
|
|
1,449
|
|
|
11,717
|
|
2026
|
|
1,063
|
|
|
11,073
|
|
Later years
|
|
7,527
|
|
|
54,562
|
|
Total minimum lease payments
|
|
23,153
|
|
|
126,190
|
|
Amounts representing interest
|
|
2,410
|
|
|
11,283
|
|
Present value of minimum lease payments
|
|
$
|
20,743
|
|
|
$
|
114,907
|
|
Rental expense for operating leases during the fiscal years ended October 31, 2021, 2020 and 2019 was $20,618, $22,061 and $19,131, respectively.
Capitalized net finance leases included in property, plant and equipment during the fiscal years ended October 31, 2021 and October 31, 2020 was $19,745 and $15,659, respectively.
Note 12 — Fair value measurements
The inputs to the valuation techniques used to measure fair value are classified into the following categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2021
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
Assets:
|
|
|
|
|
|
|
|
Foreign currency forward contracts (a)
|
$
|
2,755
|
|
|
$
|
—
|
|
|
$
|
2,755
|
|
|
$
|
—
|
|
Total assets at fair value
|
$
|
2,755
|
|
|
$
|
—
|
|
|
$
|
2,755
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
Deferred compensation plans (b)
|
$
|
9,115
|
|
|
$
|
—
|
|
|
$
|
9,115
|
|
|
$
|
—
|
|
Foreign currency forward contracts (a)
|
4,507
|
|
|
—
|
|
|
4,507
|
|
|
—
|
|
Total liabilities at fair value
|
$
|
13,622
|
|
|
$
|
—
|
|
|
$
|
13,622
|
|
|
$
|
—
|
|
Notes to Consolidated Financial Statements — (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 2020
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
Assets:
|
|
|
|
|
|
|
|
Foreign currency forward contracts (a)
|
$
|
2,700
|
|
|
$
|
—
|
|
|
$
|
2,700
|
|
|
$
|
—
|
|
Total assets at fair value
|
$
|
2,700
|
|
|
$
|
—
|
|
|
$
|
2,700
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
Deferred compensation plans (b)
|
$
|
12,304
|
|
|
$
|
—
|
|
|
$
|
12,304
|
|
|
$
|
—
|
|
Foreign currency forward contracts (a)
|
5,937
|
|
|
—
|
|
|
5,937
|
|
|
—
|
|
Total liabilities at fair value
|
$
|
18,241
|
|
|
$
|
—
|
|
|
$
|
18,241
|
|
|
$
|
—
|
|
(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.
(b)Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Fair value disclosures related to goodwill and indefinite-lived intangible assets are disclosed in Note 6.
The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
Carrying
Amount
|
|
Fair Value
|
|
Carrying
Amount
|
|
Fair Value
|
Long-term debt (including current portion)
|
$
|
812,352
|
|
|
$
|
855,376
|
|
|
$
|
1,105,995
|
|
|
$
|
1,170,073
|
|
We used the following methods and assumptions in estimating the fair value of financial instruments:
•Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs as described in Note 10.
Note 13 — Derivative financial instruments
We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statement of Income together with the transaction gain or loss from the related balance sheet position.
In 2021, we recognized net gains of $1,485 on foreign currency forward contracts and net losses of $7,411 from the change in fair value of balance sheet positions. In 2020, we recognized net losses of $5,899 on foreign currency forward contracts and net gains of $4,367 from the change in fair value of balance sheet positions. In 2019, we recognized net gains of $2,373 on foreign currency forward contracts and net losses of $2,231 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivables-net and Accrued liabilities, respectively in the Consolidated Balance Sheets.
Notes to Consolidated Financial Statements — (Continued)
The following table summarizes, by currency, the contracts outstanding at October 31, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional Amounts
|
|
Sell
|
|
Buy
|
October 31, 2021 contract amounts:
|
|
|
|
Euro
|
$
|
100,922
|
|
|
$
|
325,581
|
|
Pound sterling
|
50,333
|
|
|
79,934
|
|
Japanese yen
|
14,338
|
|
|
45,436
|
|
Australian dollar
|
709
|
|
|
10,088
|
|
Hong Kong dollar
|
6,948
|
|
|
44,831
|
|
Singapore dollar
|
200
|
|
|
18,029
|
|
Others
|
16,367
|
|
|
86,492
|
|
Total
|
$
|
189,817
|
|
|
$
|
610,391
|
|
October 31, 2020 contract amounts:
|
|
|
|
Euro
|
$
|
127,849
|
|
|
$
|
259,510
|
|
Pound sterling
|
36,943
|
|
|
71,380
|
|
Japanese yen
|
23,262
|
|
|
41,133
|
|
Australian dollar
|
179
|
|
|
9,084
|
|
Hong Kong dollar
|
59,459
|
|
|
81,199
|
|
Singapore dollar
|
1,102
|
|
|
17,350
|
|
Others
|
6,985
|
|
|
73,310
|
|
Total
|
$
|
255,779
|
|
|
$
|
552,966
|
|
We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. As of October 31, 2021 and 2020, there were no significant concentrations of credit risk.
Note 14 — Capital shares
Preferred — We have authorized 10,000 Series A convertible preferred shares without par value. No preferred shares were outstanding in 2021, 2020 or 2019.
Common — We have 160,000 authorized common shares without par value. At October 31, 2021 and 2020, there were 98,023 common shares issued. At October 31, 2021 and 2020, the number of outstanding common shares, net of treasury shares, was 58,154 and 58,081, respectively.
Common shares repurchased as part of publicly announced programs during 2021, 2020 and 2019 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
Number
of Shares
|
|
Total
Amount
|
|
Average
per Share
|
2021
|
262
|
|
|
55,033
|
|
|
$
|
209.97
|
|
2020
|
303
|
|
|
38,138
|
|
|
$
|
125.70
|
|
2019
|
949
|
|
|
114,790
|
|
|
$
|
121.01
|
|
These amounts exclude share repurchases associated with employee equity award exercises and vesting.
Note 15 — Stock-based compensation
During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the “2021 Plan”) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the "2012 Plan"). The 2021 plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that were available to be granted under the 2012 Plan. As of October 31, 2021, a total of 2,253 common shares were available to be granted under the 2021 Plan.
Notes to Consolidated Financial Statements — (Continued)
Stock options — Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25 percent per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $6,946, $10,087 and $10,067 for 2021, 2020 and 2019, respectively.
The following table summarizes activity related to stock options during 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Options
|
|
Weighted˗Average
Exercise Price
Per Share
|
|
Aggregate
Intrinsic
Value
|
|
Weighted˗Average
Remaining
Term
|
Outstanding at October 31, 2020
|
1,487
|
|
|
$
|
122.45
|
|
|
|
|
|
Granted
|
93
|
|
|
$
|
201.43
|
|
|
|
|
|
Exercised
|
(298)
|
|
|
$
|
107.14
|
|
|
|
|
|
Forfeited or expired
|
(47)
|
|
|
$
|
152.52
|
|
|
|
|
|
Outstanding at October 31, 2021
|
1,235
|
|
|
$
|
130.93
|
|
|
$
|
152,304
|
|
|
6.1 years
|
Expected to vest
|
561
|
|
|
$
|
155.55
|
|
|
$
|
55,335
|
|
|
7.3 years
|
Exercisable at October 31, 2021
|
671
|
|
|
$
|
110.21
|
|
|
$
|
96,638
|
|
|
5.0 years
|
Summarized information on currently outstanding options follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of Exercise Price
|
|
$43 - $90
|
|
$91 - $140
|
|
$141 - $201
|
Number outstanding
|
204
|
|
|
626
|
|
|
405
|
|
Weighted-average remaining contractual life, in years
|
3.1
|
|
6.3
|
|
8.3
|
Weighted-average exercise price
|
$
|
71.82
|
|
|
$
|
122.31
|
|
|
$
|
174.09
|
|
Number exercisable
|
204
|
|
|
399
|
|
|
68
|
|
Weighted-average exercise price
|
$
|
71.82
|
|
|
$
|
120.24
|
|
|
$
|
167.15
|
|
As of October 31, 2021, there was $8,003 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.1 years.
The fair value of each option grant was estimated at the date of the grant using the Black-Scholes option-pricing model with the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Expected volatility
|
30.8%-32.6%
|
|
24.5%-30.5%
|
|
24.1%-24.5%
|
Expected dividend yield
|
0.83%-0.85%
|
|
0.87%-1.16%
|
|
1.04%
|
Risk-free interest rate
|
0.43%-0.77%
|
|
0.44%-1.69%
|
|
2.84%-2.95%
|
Expected life of the option (in years)
|
5.3-6.2
|
|
5.3-6.3
|
|
5.3-6.2
|
The weighted-average expected volatility used to value options granted in 2021, 2020 and 2019 was 31.0 percent, 25.4 percent and 24.3 percent, respectively.
Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of United States Treasury issues with terms equal to the expected life of the option being valued.
The weighted average grant date fair value of stock options granted during 2021, 2020 and 2019 was $56.02, $38.57 and $31.74, respectively.
The total intrinsic value of options exercised during 2021, 2020 and 2019 was $32,791, $65,783 and $31,881, respectively.
Cash received from the exercise of stock options for 2021, 2020 and 2019 was $31,780, $50,853 and $26,020, respectively.
Notes to Consolidated Financial Statements — (Continued)
Restricted shares and restricted share units — We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a gateway performance measure that must be achieved for the restricted share units to vest.
For employee recipients, in the event of termination of employment due to early retirement, with consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units.
For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units.
As shares or units are issued, deferred stock-based compensation equivalent to the fair market value on the date of grant is expensed over the vesting period.
The following table summarizes activity related to restricted shares during 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
Weighted˗Average
Grant Date Fair
Value Per Share
|
Restricted at October 31, 2020
|
58
|
|
|
$
|
148.75
|
|
Granted
|
—
|
|
|
$
|
—
|
|
Forfeited
|
(6)
|
|
|
$
|
162.94
|
|
Vested
|
(33)
|
|
|
$
|
141.32
|
|
Restricted at October 31, 2021
|
19
|
|
|
$
|
157.36
|
|
As of October 31, 2021, there was $1,409 of unrecognized compensation cost related to restricted shares. The cost is expected to be amortized over a weighted average period of 0.7 years. The amount charged to expense related to restricted shares was $2,054, $3,956 and $3,608 in 2021, 2020 and 2019, respectively. These amounts included common share dividends of $43, $87 and $84 in 2021, 2020 and 2019, respectively.
The following table summarizes activity related to restricted share units in 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Units
|
|
Weighted˗Average Grant Date Fair
Value
|
Restricted share units at October 31, 2020
|
—
|
|
|
$
|
—
|
|
Granted
|
87
|
|
|
$
|
202.41
|
|
Forfeited
|
(14)
|
|
|
$
|
202.06
|
|
Vested
|
(6)
|
|
|
$
|
198.58
|
|
Restricted share units at October 31, 2021
|
67
|
|
|
$
|
202.81
|
|
As of October 31, 2021, there was $8,573 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 0.9 years. The amounts charged to expense related to restricted share units in 2021, 2020 and 2019 were $6,264, $1,181 and $1,052, respectively. Restricted share unit expense increased in 2021 compared to prior years as the granting of restricted share units has generally replaced the granting of stock options for key employees.
Performance share incentive awards — Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved.
The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards granted in 2021. The per share values were $202.05 for 2021;
Notes to Consolidated Financial Statements — (Continued)
$201.50 modified per share value compared to original per share values of $160.02, $133.01 and $184.04 for 2020; and $120.12 and $138.53 for 2019. The amount charged to expense for executive officers and selected other key employees in 2021 was $7,178. The amount credited to expense in 2020 was $2,732 and the amount charged to expense in 2019 was $2,989. The cumulative amount recorded in shareholders’ equity at October 31, 2021 and 2020 was $7,015 and $1,557, respectively. As of October 31, 2021, there was $15,271 of unrecognized compensation cost related to performance share incentive awards.
Deferred compensation — Our executive officers and other highly compensated employees may elect to defer up to 100 percent of their base pay and cash incentive compensation and, for executive officers, up to 90 percent of their share-based performance incentive award payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan was $96, $276 and $300 for 2021, 2020 and 2019, respectively.
Deferred directors’ compensation — Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared.
The following table summarizes activity related to director deferred compensation share equivalent units during 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
Weighted˗Average
Grant Date Fair
Value Per Share
|
Outstanding at October 31, 2020
|
120
|
|
|
$
|
60.81
|
|
Restricted stock units vested
|
4
|
|
|
$
|
199.36
|
|
Dividend equivalents
|
1
|
|
|
$
|
215.03
|
|
Distributions
|
(19)
|
|
|
$
|
58.86
|
|
Outstanding at October 31, 2021
|
106
|
|
|
$
|
68.11
|
|
The amount charged to expense related to director deferred compensation was $262, $175 and $154 in 2021, 2020 and 2019, respectively.
Shares reserved for future issuance — At October 31, 2021, there were 1,835 of common shares reserved for future issuance through the exercise of outstanding options or rights.
Note 16 — Operating segments and geographic area data
We conduct business in two primary operating segments: Industrial Precision Solutions and Advanced Technology Solutions. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Consolidated Statement of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are generally the same as those described in Note 1, Significant Accounting Policies.
Effective in the second quarter of 2020, we made changes to realign our management team and our operating segments. This realignment will enable us to better serve global customers and markets, to more efficiently leverage technology synergies, to operate divisions of significant size in a consistent and focused way and to position ourselves for our next chapter of profitable growth. The revised operating segments better reflect how we manage the Company, allocate resources, and assess performance of the businesses.
We realigned our former three operating segments into two: Industrial Precision Solutions and Advanced Technology Solutions. Existing product lines were unchanged as part of this new structure.
Industrial Precision Solutions: This segment combines our former Adhesive Dispensing Systems (ADS) and Industrial Coating Systems (ICS) businesses. IPS enhances the technology synergies between ADS and ICS to deliver proprietary dispensing and processing technology to diverse end markets. Product lines reduce material consumption, increase line efficiency and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, consumer durables and non-durables markets.
Advanced Technology Solutions: This segment integrates our proprietary product technologies found in progressive stages of a customer’s production processes, such as surface treatment, precisely controlled dispensing of material and post-dispense test
Notes to Consolidated Financial Statements — (Continued)
and inspection to ensure quality. Related single-use plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons and catheters are used to dispense or control fluids in production processes or within customers’ end products. This segment predominantly serves customers in the electronics, medical and related high-tech industrial markets.
The financial information presented herein reflects the impact of the preceding changes and prior periods have been revised to reflect these changes.
No single customer accounted for 10 percent or more of sales in 2021, 2020 or 2019.
The following table presents information about our reportable segments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Precision Solutions
|
|
Advanced Technology Solutions
|
|
Corporate
|
|
Total
|
Year ended October 31, 2021
|
|
|
|
|
|
|
|
Net external sales
|
$
|
1,246,947
|
|
|
$
|
1,115,262
|
|
|
$
|
—
|
|
|
$
|
2,362,209
|
|
Depreciation and amortization
|
25,673
|
|
|
68,426
|
|
|
9,784
|
|
|
103,883
|
|
Operating profit (loss)
|
414,192
|
|
|
271,660
|
|
|
(70,725)
|
|
|
615,127
|
|
Identifiable assets (b)
|
898,051
|
|
|
1,902,637
|
|
|
967,796
|
|
(a)
|
3,768,484
|
|
Property, plant and equipment expenditures
|
9,009
|
|
|
23,064
|
|
|
6,230
|
|
|
38,303
|
|
Year ended October 31, 2020
|
|
|
|
|
|
|
|
Net external sales
|
$
|
1,143,423
|
|
|
$
|
977,677
|
|
|
$
|
—
|
|
|
$
|
2,121,100
|
|
Depreciation and amortization
|
38,939
|
|
|
64,543
|
|
|
9,820
|
|
|
113,302
|
|
Operating profit (loss)
|
208,028
|
|
|
191,602
|
|
|
(50,085)
|
|
|
349,545
|
|
Identifiable assets (b)
|
882,946
|
|
|
1,849,391
|
|
|
948,048
|
|
(a)
|
3,680,385
|
|
Property, plant and equipment expenditures
|
18,545
|
|
|
31,520
|
|
|
470
|
|
|
50,535
|
|
Year ended October 31, 2019
|
|
|
|
|
|
|
|
Net external sales
|
$
|
1,208,376
|
|
|
$
|
985,850
|
|
|
$
|
—
|
|
|
$
|
2,194,226
|
|
Depreciation and amortization
|
38,333
|
|
|
62,836
|
|
|
9,075
|
|
|
110,244
|
|
Operating profit (loss)
|
329,054
|
|
|
205,609
|
|
|
(51,550)
|
|
|
483,113
|
|
Identifiable assets (b)
|
997,460
|
|
|
1,740,259
|
|
|
782,188
|
|
(a)
|
3,519,907
|
|
Property, plant and equipment expenditures
|
30,400
|
|
|
26,010
|
|
|
7,834
|
|
|
64,244
|
|
(a)Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities, the major portion of our enterprise management system, and intangible assets. Includes assets held for sale in 2020, see Note 4.
(b)Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill.
Notes to Consolidated Financial Statements — (Continued)
We have significant sales and long-lived assets in the following geographic areas:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Net external sales
|
|
|
|
|
|
United States
|
$
|
789,303
|
|
|
$
|
755,642
|
|
|
$
|
758,383
|
|
Americas
|
179,807
|
|
|
141,473
|
|
|
167,661
|
|
Europe
|
617,492
|
|
|
536,636
|
|
|
571,596
|
|
Japan
|
107,572
|
|
|
126,601
|
|
|
126,756
|
|
Asia Pacific
|
668,035
|
|
|
560,748
|
|
|
569,830
|
|
Total net external sales
|
$
|
2,362,209
|
|
|
$
|
2,121,100
|
|
|
$
|
2,194,226
|
|
Long-lived assets
|
|
|
|
|
|
United States
|
$
|
311,254
|
|
|
$
|
329,390
|
|
|
$
|
286,894
|
|
Americas
|
11,624
|
|
|
2,307
|
|
|
1,948
|
|
Europe
|
67,776
|
|
|
69,854
|
|
|
44,041
|
|
Japan
|
18,318
|
|
|
22,733
|
|
|
6,169
|
|
Asia Pacific
|
57,444
|
|
|
56,459
|
|
|
59,843
|
|
Total long-lived assets
|
$
|
466,416
|
|
|
$
|
480,743
|
|
|
$
|
398,895
|
|
Long-lived assets includes property, plant and equipment - net and operating right of use lease assets, which were recorded as a result of the new lease standard as codified in ASC 842 and excludes amounts held for sale in 2020, see Note 4. The increase in 2020 was driven primarily by the recording of the operating right of use lease assets.
A reconciliation of total segment operating profit to total consolidated income before income taxes is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Total profit for reportable segments
|
$
|
615,127
|
|
|
$
|
349,545
|
|
|
$
|
483,113
|
|
Interest expense
|
(25,491)
|
|
|
(32,160)
|
|
|
(47,145)
|
|
Interest and investment income
|
2,150
|
|
|
1,681
|
|
|
1,844
|
|
Other-net
|
(17,610)
|
|
|
(17,577)
|
|
|
(6,708)
|
|
Income before income taxes
|
$
|
574,176
|
|
|
$
|
301,489
|
|
|
$
|
431,104
|
|
A reconciliation of total assets for reportable segments to total consolidated assets is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Total identifiable assets for reportable segments
|
$
|
3,768,484
|
|
|
$
|
3,680,385
|
|
|
$
|
3,519,907
|
|
Customer advance payments
|
77,868
|
|
|
42,323
|
|
|
41,131
|
|
Eliminations
|
(55,391)
|
|
|
(48,052)
|
|
|
(44,591)
|
|
Total consolidated assets
|
$
|
3,790,961
|
|
|
$
|
3,674,656
|
|
|
$
|
3,516,447
|
|
Note 17 — Supplemental information for the statement of cash flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
Cash operating activities:
|
|
|
|
|
|
Interest paid
|
$
|
27,122
|
|
|
$
|
31,095
|
|
|
$
|
50,578
|
|
Income taxes paid
|
106,942
|
|
|
80,849
|
|
|
104,326
|
|
Notes to Consolidated Financial Statements — (Continued)
Note 18 — Contingencies
We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. Including the litigation and environmental matters discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.
Class Action Litigation
On February 22, 2019, a former employee, Mr. Ortiz, filed a purported class action lawsuit in the San Diego County Superior Court, California, against Nordson Asymtek, Inc. and Nordson Corporation, alleging various violations of the California Labor Code. Plaintiff seeks, among other things, an unspecified amount for unpaid wages, actual, consequential and incidental losses, penalties, and attorneys’ fees and costs. Following mediation in June 2020, the parties agreed to settle the lawsuit, subject to the execution of a written settlement agreement and court approval. In November 2021, we received final court approval of the settlement on the previously agreed upon terms. Management believes, based on currently available information, that the ultimate outcome of the proceeding described above will not have a material adverse effect on our financial condition or results of operations.
Environmental
We have voluntarily agreed with the City of New Richmond, Wisconsin and other Potentially Responsible Parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the “Site”) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. At October 31, 2021 and October 31, 2020, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was $319 and $360, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.
Note 19 — Subsequent Events
On August 24, 2021, we entered into an agreement to acquire NDC Technologies (NDC), a leading global provider of precision measurement solutions for in-line manufacturing process control. NDC's technology portfolio includes in-line measurement sensors, gauges and analyzers using near-infrared, laser, X-ray, optical and nucleonic technologies, as well as proprietary algorithms and software. The acquisition, which was completed on November 1, 2021, expanded our test and inspection platform and will be reported in our Advanced Technology Solutions segment. The all-cash transaction of approximately $180,000 was funded using cash from operations and is not expected to have a material impact on our consolidated financial statements.
Management’s Report on Internal Control Over Financial Reporting
The management of Nordson Corporation is responsible for establishing and maintaining adequate internal control over financial reporting.
Using criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013 framework), Nordson’s management assessed the effectiveness of our internal control over financial reporting as of October 31, 2021.
Based on our assessment, management concluded that our internal control over financial reporting was effective as of October 31, 2021.
The independent registered public accounting firm, Ernst & Young LLP, has also audited the effectiveness of our internal control over financial reporting as of October 31, 2021. Their report is included herein.
|
|
|
|
|
|
|
|
|
/s/ Sundaram Nagarajan
|
|
/s/ Joseph P. Kelley
|
President and Chief Executive Officer
|
|
Executive Vice President, Chief Financial Officer
|
|
|
|
December 17, 2021
|
|
December 17, 2021
|
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Nordson Corporation
Opinion on Internal Control over Financial Reporting
We have audited Nordson Corporation’s internal control over financial reporting as of October 31, 2021, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Nordson Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of October 31, 2021, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of October 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended October 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated December 17, 2021 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Cleveland, Ohio
December 17, 2021
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Nordson Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Nordson Corporation (the Company) as of October 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended October 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at October 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended October 31, 2021, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of October 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated December 17, 2021 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.
|
|
|
|
|
|
|
|
|
|
|
Valuation of Goodwill
|
Description of the Matter
|
|
At October 31, 2021, the Company had $1,713,148 thousand of goodwill. As discussed in Note 6 to the consolidated financial statements, the Company evaluates the carrying amount of goodwill for impairment annually as of August 1, and between annual evaluations if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets. The Company performed a quantitative impairment test for all reporting units in fiscal 2021. As part of the quantitative impairment test, the Company estimated the fair value of each reporting unit using a combination of valuation techniques including the discounted cash flow method, a form of the income approach, and the guideline public company method, a form of the market approach.
Auditing management’s annual goodwill impairment assessment relating to goodwill was complex due to the use of valuation methodologies in the determination of the estimated fair values of the reporting units. These fair value estimates are impacted by assumptions such as the selection of comparable guideline companies and the related valuation multiples, as well as discount rates, revenue growth rates, and operating margins which are affected by expectations about future market or economic conditions.
|
|
|
|
How We Addressed the Matter in Our Audit
|
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s goodwill impairment process whereby the Company develops assumptions that are used as inputs to the annual goodwill impairment test. This included controls over management's review of the valuation models and the assumptions, described above.
To test the implied fair value of the Company’s reporting units, we performed audit procedures that included, among others, assessing the valuation methodologies, testing the assumptions, and testing the completeness and accuracy of the underlying data. We involved our internal valuation specialists in assessing the fair value methodologies applied and evaluating the reasonableness of certain assumptions selected by management. We assessed the historical accuracy of management’s estimates and performed sensitivity analyses of assumptions to evaluate the changes in the fair value of the reporting units that would result from changes in the assumptions. We tested management’s reconciliation of the fair value of the reporting units to the market capitalization of the Company. We also assessed the appropriateness of the disclosures in the consolidated financial statements.
|
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 1956.
Cleveland, Ohio
December 17, 2021
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
(a)Evaluation of disclosure controls and procedures. Our management, with the participation of the principal executive officer (president and chief executive officer) and the principal financial officer (executive vice president and chief financial officer), has reviewed and evaluated our disclosure controls and procedures (as defined in the Securities Exchange Act Rule 13a-15e) as of October 31, 2021. Based on that evaluation, our management, including the principal executive and financial officers, has concluded that our disclosure controls and procedures were effective as of October 31, 2021 in ensuring that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and is accumulated and communicated to our management, including the principal executive officer and the principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b)Management’s report on internal control over financial reporting. The Report of Management on Internal Control over Financial Reporting and the Report of Independent Registered Public Accounting Firm thereon are set forth in Part II, Item 8 of this annual report and are incorporated by reference.
(c)Changes in internal control over reporting. There were no changes in our internal controls over financial reporting that occurred during the fourth quarter of 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.
Item 9C. Disclosures Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
PART III
Item 10. Directors, Executive Officers and Corporate Governance
The information required by this Item is incorporated by reference to the captions “Proposal 1: Election of Directors Whose Terms Expire in 2025” and "Security Ownership of Nordson Common Shares by Directors, Director Nominees, Executive Officers, and Large Beneficial Owners—Delinquent Section 16(a) Reports” of our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders. Information regarding the Audit Committee and Audit Committee financial experts is incorporated by reference to the caption “Committees of the Board of Directors” of our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders.
Our executive officers serve for a term of one year from date of election to the next organizational meeting of the board of directors and until their respective successors are elected and qualified, except in the case of death, resignation or removal. Information concerning executive officers is contained in Part I of this annual report under the caption “Information about Our Executive Officers.”
We have adopted a code of ethics and business conduct for all employees and directors, including the principal executive officer, other executive officers, principal financial officer and other finance personnel. A copy of the code of ethics is available free of charge on our Web site at http://www.nordson.com/en/our-company/corporate-governance. We intend to satisfy our disclosure requirement under Item 5.05 of Form 8-K regarding any amendment to or waiver of a provision of our code of ethics and business conduct that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions and that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation S-K by posting such information on our Web site.
Item 11. Executive Compensation
The information required by this Item is incorporated by reference to the “Executive Compensation Discussion and Analysis” section of the definitive Proxy Statement for the 2022 Annual Meeting of Shareholders, along with the sections captioned “Directors Compensation,” “Summary Compensation for Fiscal Year 2021,” “Grants of Plan-Based Awards,” “Outstanding Equity Awards at October 31, 2021,” “Stock Option Exercises and Stock Vested Tables,” “Pension Benefits,” “Nonqualified Deferred Compensation,” “Potential Benefits Upon Termination or Change of Control,” “CEO Pay Ratio,” "Risks Related to Executive Compensation Policies and Practices," "Compensation Committee Report" and "Compensation Committee Interlocks and Insider Participation" in our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this Item is incorporated by reference to the caption “Security Ownership of Nordson Common Shares by Directors, Director Nominees, Executive Officers and Large Beneficial Owners” in our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders.
Equity Compensation Plan Information
The following table sets forth (in whole shares) information regarding equity compensation plans in effect as of October 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan category
|
|
Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights (1)
|
|
Weighted-average
exercise price of
outstanding options,
warrants and rights (2)
|
|
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
first reporting column) (3)
|
Equity compensation plans approved by
security holders
|
|
1,628,707
|
|
|
$
|
130.93
|
|
|
2,253,249
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
|
1,628,707
|
|
|
$
|
130.93
|
|
|
2,253,249
|
|
(1) The number of shares reported may overstate dilution due to the inclusion of performance-based awards at their maximum payout level.
(2) Full value equity awards such as performance share incentive awards are not taken into account in the weighted-average price, as such awards have no exercise price.
(3) As of October 31, 2021, includes shares available for future issuance under the 2021 Plan, including for awards other than options, warrants and rights.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this Item is incorporated by reference to the captions “Corporate Governance—Director Independence” and “Corporate Governance—Review of Transactions with Related Persons” in our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders.
Item 14. Principal Accountant Fees and Services
The information required by this Item is incorporated by reference to the caption “Proposal 2: Ratify the Appointment of Independent Registered Public Accounting Firm—Fees Paid to Ernst & Young LLP” and the caption “Proposal 2: Ratify the Appointment of Independent Registered Public Accounting Firm—Pre-Approval of Audit and Non-Audit Services” in our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders.